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ABSTRACT

Diagnostic assays are designed to detect a unique analyte profile in a disease
of interest. Nucleic acids contain an information-dense sequence, and thus are ideal
candidates for unique analytes. The gold-standard of nucleic-acid-based detection
is PCR which has high sensitivity, but involves time, expertise, and cost. DNA
molecular logic technology holds much promise as an alternative molecular
detection method due to the potential to save cost and expertise, while also
achieving a high sensitivity. However, nucleic acid detection in biomedical
applications carries with it the difficulty of choice of appropriate sequence and
potential biological sample background.
This work describes the development and testing of a DNA molecular logic
implementation of a viral assay for dengue virus. This work initiated with an attempt
at an implementation of a solution-based viral assay. The challenges arising from
the solution-based implementation, suggested the need for additional tools and
designs, and have given rise to the computational aims. Included in this work is the
vii

development of computational tools for aiding the design of DNA molecular logic
bioassays, and the use of these tools in bioassay design. The tools developed are a
continuous kinetic model of the DNA-based assay elements, a discrete stochastic
model to characterize limit of detection, and an algorithm to search databases for
assay target sequences. The result of this work are tools that may be used in the
context of DNA-based bioassay design. Future directions suggest work on
developments to the bioassay. These include an acoustophoretic microparticlebased assay for signal enrichment and a microarray-based host gene expression
profile.
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Chapter 1.
Introduction.

1.1 Infectious Disease Resurgence
In the not too distant past, the state of medical advances with respect to
infectious disease was such that it was said that infectious disease was no longer a
concern and would be eradicated in the near future. The last case of smallpox had
been seen in 1979 and the 33rd World Health Assembly declared successful
eradication of the virus in 19801. Antibiotics were keeping people safe from bacterial
infections, and programs were established to eradicate polio2, dracunculiasis, yaws,
and malaria. Other programs are in existence to eradicate or eliminate other
infectious diseases. In 2000, measles was eliminated from the United States.
However, we have seen resurgence in infectious disease in recent years due to a
number of factors. Due to the anti-vaccine movement, measles has reappeared in
the United States in 2015. Due to a failure of will to continue vector eradication
programs, the Aedes aegypti mosquito, the primary vector for dengue virus was
reintroduced into the Americas and has spread since. Climate change also worsens
this problem, as warming temperatures move climate zones that are favorable for
these vectors further into what was once considered the temperate regions, resulting
in a higher risk of tropical illnesses becoming endemic in these new areas. Disease
vectors are also spreading due to globalization. The movement of people and goods
around the world at unprecedented levels results in movement of other biologicals
into new zones, an example of which is the spread of Aedes albopictus mosquito
into Europe during the 80s with the used tire trade. Another factor caused by
1

political problems is warfare or targeting of aid workers in areas of endemic disease.
Due to overuse of antibiotics in medicine and the agriculture and livestock industries,
organisms that are resistant have emerged and are spreading. With biotechnology
becoming cheaper and more accessible to rogue agents, there is also always the
risk of intentional spreading of biohazardous materials and organisms.
With the increasing threat to human welfare and world health that infectious
disease poses, it is imperative to develop pathogen detection methods that are rapid
to deploy, easy to use, portable, and reliable. Current methods for detection of
infectious disease vary depending on the pathogen of interest but can range from
time- and expertise-intensive methods, such as culture, to assays that can be used
in the field, such as colorimetric, protein-based assays. The more reliable methods
tend to require laboratories and trained technicians to administer and run. However,
with the continued threat of new, emerging and existing infectious diseases, and the
need for epidemiological monitoring and quick clinical response in resource-limited
setting, it is crucial to develop portable, inexpensive and accurate pathogen
detection assays.

1.2 Dengue Virus Threat
While there are a number of pathogens that merit attention, a focus on
tropical diseases is important as the endemic range of these illnesses is spreading.
Many of these tropical illnesses are spread by an insect vector, and so are called
arboviruses. The most prevalent of arboviruses, dengue virus is thus an important
target for detection. Currently, 40% of the world’s population (or about 3 billion
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individuals) live in dengue endemic areas. Using dengue virus as a case study for
pathogen detection, this work seeks to design, improve upon, and validate a DNAlogic based assay using wet-lab characterization and in silico modelling and design.
Dengue virus causes a febrile illness characterized by malaise, fever, severe
headaches, joint and muscle pain, nausea, vomiting, rashes, bleeding gums and
nose, and easy bruising that can progress to a more deadly illness. The more
advanced forms of dengue illness were once known as Dengue Hemorrhagic Fever
(DHF) and Dengue Shock Syndrome (DSS). DHF is characterized by bleeding, high
fever, damage to lymph and blood vessels, enlarged liver, circulatory failure, and
higher risk of death. There are 50 to 100 million dengue infections annually. Of
these, 500,000 cases of DHF occur each year resulting in 22,000 deaths. DSS
results in massive bleeding, shock, and death. WHO currently recommends dengue
case classification by severity: dengue with or without warning signs, and severe
dengue3.
There is a need to be able to detect dengue early as it presents similarly to
many other febrile tropical illnesses that may be of less concern and immediate
treatment decisions can save the dengue patient’s life4. Furthermore, it is of
importance to be able to discriminate serotype of dengue virus as this is both of
clinical and epidemiological importance. Due to antibody-dependent enhancement5–
8,

serotype can affect the course of the illness. Exposure to a single serotype of

dengue with subsequent convalescence will result in a typical immunity to that
serotype of the virus. There will typically be resistance to acquiring the other viral
serotypes for some time after this, but the cross-viral protection will diminish and
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then result in the antibody-dependent enhancement, whereby the similarity in
epitopes, instead of conferring advantage in immunity, instead causes overreaction
of the immune response, resulting in worse disease. Knowing the initial serotype of
infection and the serotype of a new exposure will give some knowledge as to the
prognosis of the disease and inform treatment decisions9. Additionally, it is of
epidemiological importance to know the serotype and strain of illness in order to
track spread of virus and predict and track potential outbreaks9.
The existing tests for diagnosis of dengue fall into one of these categories:
serologic diagnosis, viral isolation, and molecular detection10. The common
serological viral antigen detection assay tests for NS1 antigen, which can be done
early, is definitive, and serotype specific. This test is useful up to 5 days post-fever
onset, as NS1 is only detectable for nine days9. Typically, a serologic test such as
an enzyme-linked immunosorbent assays (ELISA) is performed after the first week
of infection, as this tests for host antibody response in IgG or IgM. In addition to
ELISAs, other serologic test options are hemagglutination-inhibition, complement
fixation, and plaque-reduction neutralization test10. Viral isolation is the most time
and resource intensive option and involves inoculation of tissue types for culturing of
virus and is usually only performed by the CDC. Molecular detection refers to
nucleic acid-based assays and as such can only be performed during the period of
viremia: the first 4 to 6 days of illness. These tests fall with the rubric of nucleic acid
amplification tests (NAATs) such as PCR. The burgeoning field of nucleic acidbased logic devices as biosensor falls best into the category of molecular detection.

4

1.3 Diagnosis by Assay
Assays are analytical methods with circumscribed and prescribed
methodology and interpretation. A bioassay is a specific type of assay that uses a
biological test system to assess biological activity and interaction of the analyte in
question11. Bioassays may be used in the assessment of candidate drugs, or in
detection and diagnosis of illness. Among the candidate biomolecules used in
bioassays are lipids, proteins, and nucleic acids which may be used individually or
together. While there are important assays that make use of lipids or proteins as
fundamental aspects of detection, we will focus on DNA-based assays here. We are
most interested in nucleic-acid logic-based biosensors, but the closely-related and
overlapping technologies of nucleic acid amplification tests (NAATs) will be
discussed first.
DNA is a promising choice for a biosensor, particularly if the target analyte is
also nucleic acid. Furthermore, it is advantageous to design DNA nanostructures for
assays due to DNA’s well-characterized thermodynamics12–14. The free energies of
sequence-dependent nearest neighbor interactions has been determined by
laboratory exploration. Existence of these derived parameters has enabled
computational tools to be designed to facilitate design of DNA structure15,16. For a
biosensor designed to detect a nucleic acid base sequence, DNA is an apt choice
for a recognition element. Due to Watson-Crick base-pairing principles, whereby
bases pair in primarily predictable fashion, DNA hybridizing to target serves as a
reasonable mechanism of interaction for sensing. If used as detector, this
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sequence-dependent interaction holds the promise of specificity as an inbuilt
advantage.

1.4 Form-factor and Design of Portable Assays
An important goal in assay design is the development of assays that are
portable and which can be used at the point of care. With emerging infectious
disease as a global problem, it is important to be able to make rapid diagnoses
regardless of locale. This means diagnostic assays should be portable enough to
bring to the bedside, should function without an external source of power, and
shouldn’t perish easily. These stipulations suggest the following qualities. The
assay should be carryable by hand (less than a pound) or by backpack (less than 10
pounds). The device should be self-powered or require no power for the test to run.
The components of the assay should be non-perishable at various temperatures,
humidities, or pressures.
Despite these stipulations, portable assays may take a variety of form-factors.
The assay device may take multiple sizes and still be portable depending on the
context. It could be the size of a vehicle (perhaps integrated into a vehicle) and
driven to the point of care. Pocket sized devices are more promising and due to
improvements in microfluidics and microfabrication, the lab-on-a-chip (LOC) is a
potential solution for a point-of-care (POC) device.
The simplicity or complexity of the assay and its components will determine
power requirements. Assays may consist only of molecular components in solution
which may require no power, or may require power enough to maintain a
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temperature to keep the components from perishing. The assay may be integrated
into a physical device, which may, in turn, either require power or be self-powered.
The type of amplification used may determine whether there is the need for onboard
power. Isothermal amplification methods, when combined with isothermal detection
obviate the need for power. This simplifies the device design and reduces failure
points.
The components for the assay may consist of biological molecules. These
may be nucleic acids, or other components, such as proteins and lipids.
Components may be solution-based, or may be fixed to a surface of a flow cell, or of
microbeads or nanoparticles. Sensor elements may be attached to a surface to
function as a signal transducer, converting detection interaction into an electrical
signal.
The work here considers an assay based on a DNA molecular logic design.
The biosensor is a system of interacting deoxyoligonucleotides which are designed
to detect a specific oligonucleotide sequence and to release a fluorescent report on
detection. The components and function of the assay are discussed below.

1.5 Nucleic Acid Amplification
An important aspect of DNA-based assay design which relates to assay
portability is the question of amplification. The analyte of interest may exist at low
levels of concentration, and as such will need to be amplified in the course of the
detection scheme. This will either need to occur in pre-processing, or should be a
process that is integrated into the assay itself.

7

Nucleic acid amplification tests (NAATs) are currently built around a unique
sequence from DNA or RNA. These assays typically have better sensitivity or
specificity than protein-based assays. Polymerase chain reaction (PCR) is the gold
standard among the so-called molecular tests. It utilizes a thermocycler, a
thermophilic polymerase, and oligonucleotide primer in the amplification and
subsequent specific detection of nucleic acids. It can detect very low copy numbers.
As a specific example, in the detection of dengue virus, PCR has been able to
achieve detection limits as low as 7.9 copies/µL17.
Assays using PCR to amplify and detect, take advantage of nucleic acid
hybridization specificity and many-fold amplification, placing it as the gold standard
for detection of small amounts of nucleic acid. While PCR is very versatile, sensitive
and specific, it uses protein components, and requires expertise and a properly
outfitted lab. In cities in the developed world, with easy access to refrigeration,
experienced technicians, and sophisticated diagnostic laboratories, this is not a
concern. In rural and underdeveloped areas, these are limiting concerns. Proteins
will readily denature if not refrigerated, and personnel and laboratories may not be
available. In these conditions portable diagnostic devices become desirable.
PCR uses a mix of reagents, including protein components in addition to the
nucleic acid primers and requires thermocycling to achieve amplification. Detection
of dengue entails amplification not of DNA, but of the viral RNA, necessitating the
use of reverse transcriptase PCR (RT-PCR). Although newer commercial methods
of RT-PCR can achieve a 10-minute reaction time18, it is still necessary to perform
prior sample preparation which can require 2 hours or more19. Samples may start
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off as a direct blood draw or a tissue biopsy from a patient. The raw sample will then
require further processing in order to extract DNA or RNA that can be used in the
diagnostic assay. Tissue must be macerated to get to subcellular components.
Blood requires anticoagulants to maintain a workable viscosity of the sample.
Subsequent to these initial steps, cells, tissue debris, and other biological
components form a biomatrix which contain and contaminate the desired nucleic
acids. Addition of detergents, chaotropes, or other active components break up
unwanted biomatrix components and maintain the nucleic acids in a denatured state.
Extraction of RNA and DNA must be performed which can involve multiples steps of
microcentrifuge filtration and application of sample and washes to the filter
membrane, followed by elution of the desired nucleic acid. These steps can be timeconsuming and require trained personnel and equipment. These are all parts of a
procedure that must be miniaturized in design of an LOC device. Avoidance of any
of these preparation steps can result in biomatrix components remaining in the
sample and impeding the diagnostic component of the assay. There have been
recent strides in miniaturization of PCR, with detection of Shiga toxin-producing E.
coli genes comparable to that of conventional PCR (defined as PCR using liquid
tubes) being realized,20–22 among other feats. PCR that has been miniaturized into a
POC device must have all the functionality of conventional PCR integrated into an
LOC. Diagnostic information must be conveyed, for example in a colorimetric
fashion in the reaction chamber or through electrochemistry23. Reverse
transcription-insulated isothermal PCR (RT-iiPCR)24 has been developed and made
portable in a commercial format (the POCKIT nucleic acid analyzer, GeneReach
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Biotechnology Corp, Taiwan). This same form factor has been used in a serotype
specific assay that achieves a 10-copy limit of detection in in vitro-transcribed
RNA25.
Isothermal amplification has inherent advantages over PCR-based
amplification, even the miniaturized versions. With detection based on roomtemperature isothermal reactions, the point-of-care device may be simplified by
removing the power source. Additionally, isothermal amplification components may
be more resilient than PCR to certain types of biomatrix contamination26. Because
of these advantages, there is much interest in exploring isothermal amplification
methods for detection. With respect to amplification of nucleic acids, there are a
number of methods that are currently being explored, including loop-mediated
isothermal amplification (LAMP)27, rolling-circle amplification (RCA)28, nucleic acid
sequence-based amplification (NASBA)29, strand displacement amplification
(SDA)30, entropy-driven catalysis (EDC)31, catalytic hairpin assembly (CHA)32, and
others. Using reverse transcription LAMP (RT-LAMP), differentiation of dengue
serotypes was possible in an assay that targeted the NS1 region of the genome33.
Another group used RT-LAMP for multiplexed detection of dengue along with five
other blood-borne pathogens with 100% specificity34.
Driven by center-of-mass configurational entropy of released molecules,
reaction systems that are composed of strand-displacement systems that can
amplify a signal have been produced, such as entropically driven catalysis31,35.
Catalytic DNA (DNAzymes, deoxyribozymes, or DNA enzymes) is singlestranded DNA that contains a subdomain with secondary structure that has catalytic
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functionality which usually requires a metal ion cofactor. The DNAzyme may be
abstracted as a loop-like region (the catalytic core), and two flanking regions (Figure
1A). The flanking regions may be given any arbitrary sequence in principle, such
that they are complementary to the substrate oligonucleotide. When the flanking
regions of the DNAzyme are hybridized to the complementary regions on the
substrate, the active site of the catalytic core is positioned to catalyze the cleavage
of a phosphodiester bond. In certain DNAzymes, one side of this bond needs to be
a ribonucleotide sugar. Once so positioned, the catalytic core catalyzes this reaction
resulting in a substrate that has been split into two products (Figure 1A).

Figure 1: Catalytic DNA. (A) DNAzymes cleave a phosphodiester junction on a
complementary oligonucleotide substrate. (B) With a fluorophore and a quencher
conjugated to either end of the substrate, the molecule will serve as a fluorescent
reporter. Due to FRET, the fluorophore is quenched, but once the substrate is
cleaved, the fluorophore can move away and fluoresce.

Our group exploits the DNAzyme functionality, by tying it to a fluorescent
report, through the use of a FRET (Förster Resonance Energy Transfer) reporter.
The substrate molecule has a fluorophore conjugated to the 5’ end of the molecule
and a quencher conjugated to the 3’ end (Figure 1B). Held within the Förster
distance by being affixed to either end of the substrate, the fluorophore and the
quencher exchange energy. The quencher absorbs energy from the fluorophore
when it is excited, preventing release of photons, and thus resulting in quenching.
11

When the substrate molecule is cleaved by the DNAzyme (Figure 1B), the
fluorophore and the quencher diffuse apart and past the Förster radius, so that the
quenching effect ceases and the fluorophore can release photons when excited.
Using this DNAzyme-substrate system allows reaction progress to be followed
through fluorometry.

1.6 Design of DNA-based Assays
In addition to amplification technologies, DNA based assays may use a
number of other basic building blocks or components. Although not an exhaustive
list of potential nucleic acid technologies, these may include strand-displacement or
toehold-mediated strand displacement (TMSD) components, aptamers, origami tiles,
and others.
Strand-displacement, or TMSD, involves a single-stranded oligonucleotide
input interacting with a double-stranded oligonucleotide complex and releasing a
single-stranded output oligonucleotide (Figure 2). TMSD relies on the basic nature
of Watson-Crick base-pairing to result in a specific interaction between
complementary sequences.
In an archetypal example of TMSD, the fundamental single-stranded
oligonucleotide species present are the input strand (orange, Figure 2A), the
template strand (black, Figure 2A), and the output strand (blue, Figure 2A). The
template strand and the output strand are complementary and are hybridized
together as a double-stranded species known as the gate complex (blue and black,
Figure 2A). The starting species in TMSD are the gate complex and the input

12

strand. While the gate is double-stranded, it has an overhanging single-stranded
region called the toehold (Figure 2B). The toehold is complementary to part of the
input strand and the input will bind to this toehold as a result. Once this interaction is
initiated, branch migration occurs (Figure 2B).
In branch migration, due to random fluctuations at thermal energy, any
particular base-pair on the gate may separate, leaving unpaired bases. When bases
unpair at the junction between the input and the output strand on the gate, the
matching base on the input strand may bind to the free base, thus displacing the
output strand’s matching base. This occurs stochastically, so may occur in either
direction. When the final products are more thermodynamically stable than the initial
reactants, usually by a net increase in the number of bases paired in going from
reactant to product, the junction will continue to propagate until the input strand fully
displaces the output strand to solution (Figure 2B).

pecies

template strand

eaction

toehold

Figure 2: Toehold-mediated Strand Displacement. See text for description.

An assay based on strand-displacement technology could take a number of
forms. Strand-displacement, itself, is a technology that can be used as a sensor,
reporter, logic-gate, or signal transducer or signal propagator. Linking together
multiple strand displacement reactions into a cascade of arbitrary size results in a
13

cascaded reaction that allows propagation of an input signal to an ultimate output.
Strand-displacement can be used in transduction of a signal when used in
conjunction with an aptamer.
An aptamer (RNA or DNA) is a single strand of oligonucleotide that binds a
unique target molecule specifically due to its secondary structure. Aptamers are
generated by an in vitro evolutionary design process known as SELEX: systematic
evolution of ligands by exponential enrichment. In this technique, aptamer
candidates are incubated with the target molecule, and those which most strongly
interact with the target are selected for and mutated. Multiple rounds of incubation,
selection, and mutation are performed until an aptamer that strongly binds its target
is selected. The target molecule may be other nucleic acids, proteins, or other small
molecules, and the SELEX process may be directed at cells and tissues 36. As
aptamers can be selected for just about any target, they can be used as a
recognition element in a biosensor. If the detection interaction is then transduced
electrochemically, these aptamers are called aptasensors37.
DNA origami has been used since its conception by Paul Rothemund to
create molecular lego bricks for fabricating any number of shapes and structures 38.
To construct an origami tile requires using a nucleic acid scaffold, such as the
M13mp18 bacteriophage genome39,40. The scaffold is held together in a threedimensional structure with short oligonucleotides called staple strands38. This
structure may take virtually any shape, but a common use in DNA nanotechnology is
simple square origami tiles that can be used for computation or pattern generation 41.
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1.7 DNA Logic Assays
ince computation using DNA was first realized in Adleman’s implementation
of molecular logic to solve the travelling salesman problem in 199442, DNA molecular
logic has seen many executions and applications. DNA molecules can be
individually realized as logic gates using strand displacement43, or catalytic DNA as
has been done with an implementation of a tic-tac-toe-playing automaton44, or both
as has been done with the universal sensor architecture45.
Assays built upon DNA logic technologies are desirable because the potential
exists to have in situ computation integrated directly into the assay. Outside of
simple assays, any assay that provides more complex output information then a
simple “yes” or “no” has to be supplemented with external in silico data processing.
Using integrated logic in the assay makes it possible to process potentially
complicated information and output a simple human-readable output. A simple
output is more amenable to being read on a point-of-care device by someone
without specialized training. This would help in the development of comprehensive
portable assays that are capable of analyzing complex analyte signatures but can
deliver universally readable information.
Basic DNA logic technologies, by nature, are capable of interfacing with other
nucleic acid technologies, particularly those of NAAT, but also with other types of
DNA elements such as aptamers, molecular beacons, and others. The primary
manner by which this can take place is through interaction of oligonucleotides with
nucleic acid sequences in toehold-mediated strand displacement (TMSD).
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TMSD may be used to form a cascade of reactions, as the output strand of
one displacement may become the input strand for a second. This allows the
stringing together of an arbitrary number of reactions in order to propagate an
oligonucleotide-based signal from the input end of the cascade to the output end.
Furthermore, since the input and output strands are nucleic acids, other nucleic acid
components may be integrated into the overall cascade. The input strand could be
an aptamer, a target sequence in a genome, or an output product of PCR. The
output strand could be a FRET reporter molecule such as a molecular beacon, a
catalytic DNA (DNAzyme), or an origami tile. In addition, logic elements may be
incorporated at any step of the way.
Nucleic acid detection has been combined with DNA logic into an integrated
system for detection of Lyssaviruses, including Rabies46. Vijayakumar and
Macdonald at Columbia University46 have engineered a system that uses mixedbase logic gates that are capable of detecting a wide range of potential sequences
due to a variable region in the input binding domain. Using “ANDNOT” gates based
off of the Stojanovic and Stefanovic design47, the components were combined into a
diagnostic automaton that delivered a dot matrix output display in a 384-well plate
that reported viral genotype46. Further work by the Columbia group has combined
these assay components with recombinase polymerase amplification and a multiplex
lateral flow device to achieve a point-of-care device that is capable of hepta-plex
readout and a dot-matrix display of results48.
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1.8 Unified Sensor Architecture for Dengue Detection and Serotyping Assay
The unified sensor architecture has been previously developed and described
by Brown et al45. The basic components of this architecture are TMSD, catalytic
DNA (DNAzyme), a FRET reporter, and hybridization-based detection.

Figure 3. Dengue Bioassay. A target sequence binds to the primary toehold, T1 on
the detection module. The target displaces the remainder of the detection module
region, exposing the secondary toehold, T2. Fuel molecule binds the secondary
toehold and displaces the remainder of the reporter region, releasing the DNAzyme.
DNAzyme assumes active conformation in solution, allowing it to cleave substrate.

The dengue bioassay uses hybridization-based detection, whereby a unique
target sequence in the genome of the virus is recognized by hybridizing with a
complementary region within the assay. Instead of naked hybridization, however,
this takes place through TMSD and thus feeds the signal of “target present” into the
assay.
The dengue assay is triggered by the presence of the target sequence from
the dengue genome (Figure 3). The primary toehold (T1) is complementary to a
portion of the target sequence (green), so that these regions will bind. Once bound
the target proceeds by TMSD and displaces the remainder of the detection module
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(also green), exposing the secondary toehold (T2). The fuel molecule (blue) is a
single-stranded oligonucleotide that is complementary to the secondary toehold and
a portion of the reporter module. It will bind to the secondary toehold and then
through TMSD will displace the remainder of the reporter module, releasing the
inactive DNAzyme into solution. Once in solution, the DNAzyme may assume its
secondary conformation and, when active, will catalyze cleavage of substrate into
two products. The two products of the substrate will diffuse apart, allowing
fluorescence to occur.
This system is designed in the interest of detecting dengue virus through
binding of the target sequence, resulting in the cascade featured in Figure 3 taking
place, with the release of a fluorescent reporter. Reaction progress of the dengue
assay may be monitored through fluorometry and presence of an appropriately high
signal will be indicative of a positive detection of dengue.
The system has the additional goal of differentiating serotypes of dengue
virus. For each of the four serotypes of dengue, a representative serotype-specific
target sequence has been chosen. An assay consisting of all the components of the
unified sensor architecture mentioned above (substrate, fuel, and enzyme/inhibitor
complex) has been designed for each serotype. For each assay corresponding to
each serotype, the detection region has been redesigned for a new target sequence.
In essence, there are four assays each with a different detection region (green)
which corresponds to the target sequence for that serotype. In principle, in the
presence of any particular target sequence, only the assay corresponding to that
target sequence should activate and release fluorescent output. By running these
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assays side-by-side, a multiplex output indicating which serotypes are present
should be possible.

1.9 Computationally-Assisted Design
Many computational tools have been used to design assays based on logicbased nucleic acid systems15,49–53. Design tools may be based on thermodynamic
or kinetic models. Most algorithms for design of nucleic acid systems are based on
equilibrium thermodynamics15,16,54–57. These tools use known parameters of nucleic
acid interactions at thermodynamic equilibrium to predict structure. Thermodynamic
constraints have been used for determining everything from optimality of
riboswitches58 to pseudoknotting in RNA59. Many of these tools are based around
manual input and design, but there is increasingly more software that automates
design. Once such computational tool designs logic-based allosteric ribozymes to
detect oligonucleotides by mutating from initial sequences49. Reinforcement learning
has been used to design RNA structures using a graph convolutional architecture 51.
A database of strategies based on human decisions in a videogame that crowdsources RNA folding60 has been used to train a convolutional neural network to
design RNA structures.61
The use of kinetic modelling for design of DNA molecular systems offers the
chance to understand the dynamic aspects of these systems. Thermodynamics may
form the base of the model, as in the case of using a free energy landscape to
demonstrate structural pathways in DNA strand displacement62. Many of the kinetic
models of DNA molecular logic mechanisms actually use molecular dynamic
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simulations62–67. Molecular statistics was used in a theoretical model of DNA walker
translocation68. Chemical reaction kinetics has been used in a simulation intended
to assist with automatic design of DNA logic elements52.
In the case of engineering DNA strand-displacement systems there are a
number of characteristics that can be explored and potentially modelled. One area
of design that might have an impact on the overall reaction profile of a cascading
strand-displacement circuit is the effect of base identity. Particularly in the case of a
mismatch, base-identity will have an impact not only on thermodynamic predictions,
but also on the kinetics of reactions that rely on Watson-Crick base pairing as a
component of the interaction. A mismatch will affect kinetics in the case of strand
displacement, a fact which can be taken advantage of for discrimination in the
design of single nucleotide probes69.
In the case of the assay target sequences were chosen by using an algorithm
written in the Python programming language to search for targets. Genome
sequences were acquired from GenBank for each of the four serotypes. The
algorithm split the genome into all possible 18-mers, then compared all of the
18mers from one genome with all the 18-mers from all the other genomes (an
oligonucleotide of length N bases is referred to as an N-mer).
Pairwise comparisons were assessed using a distance metric and
thermodynamic metrics. The Hamming distance70 compares strings of equal length,
tallying the differences at each position. For thermodynamic comparisons,
NUPACK15,16 software shows most likely nucleic acid structures from input
sequences at thermodynamic equilibrium. NUPACK uses established free
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energies12,13,71 to make this determination. Metrics used for comparison included
the normalized ensemble defect (the average percentage of incorrectly-paired
nucleotides), the unpaired probability (the probability of bases remaining unpaired at
equilibrium), and the total mean free energy of certain final structures. Manual
inspection of these metrics was performed to maximize Hamming distance, minimize
normalized ensemble defect, maximize unpaired probability, and maximize mean
free energy of acceptor-toehold structure72.

1.10 Present Studies
In this work, we have realized a unified sensor architecture design assay for
the detection of dengue virus. In addition to characterization of the physical assay,
various manipulations of the assay have been tried and proposed to deal with
various shortcomings of the assay. Additionally, in silico modelling and design
methods have been attempted in order to build tools that will provide a rational
system for development of pathogen detection approaches. The tools developed
here are two types of kinetic models and an algorithm for target selection. While the
models are currently of potential utility, future iterations will include improvements
that make them more relevant to the types of solution-based methods that are
envisioned for DNA logic-based assays.
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Chapter 2.
Goal and Overview of this Work.

The goal of this research is to advance the field of pathogen detection by
developing and characterizing an assay targeting dengue virus and developing
computational tools and models to facilitate assay development and pathogen
targeting. The two domains of this work are wet-lab implementation and
computational design tools. A DNA molecular logic bioassay for pathogen detection
has been implemented in the wet-lab and characterized. Computational tools
implemented here include a continuous kinetic model of the bioassay, a stochastic
kinetic model to characterize limit of detection, and an algorithm to search for
additional target sequences.
Although the main effort here is in the detection of dengue virus, the potential
diagnostic applications are broad. This work should be generalizable to other
pathogen-detection assays based on DNA components and DNA logic.
In preparation for journal publication, Chapter 3 describes research
characterizing the serotype-specific dengue virus assay based on the unified sensor
architecture framework. I have performed the majority of this work at the University
of New Mexico and the University of New Mexico School of Medicine and will be the
primary author. My primary advisor, Steven W. Graves, my long-term advisors,
Darko Stefanovic and Matthew R. Lakin, my advisor Andrew P. Shreve (all at the
University of New Mexico), and my committee members, Jason Gans and Ronen
Polsky (at Los Alamos National Laboratory and Sandia Laboratories respectively)
contributed guidance on experimental direction and aid with interpretation of data.
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Kathryn A. Hanley at New Mexico State University provided the cultured virus
samples used in some experiments of assay assessment. At the University of New
Mexico School of Medicine, Bryce Chackerian furnished assistance and laboratory
facilities and Susan B. Core assisted me with using the BSL2 facilities. Initial
characterization of the assay function is discussed, using a synthetic oligonucleotide
target as a stand-in for the dengue genomic target. Testing against the synthetic
target, the assay functions as expected. The assay activates and produces a report
in the presence of target, but only minimally in the absence of target, in the presence
of incorrect target, or in the presence of a complex nucleotide background. Assay
components function in bovine serum, suggesting that it may be possible to reduce
or eliminate sample preparation. Creating a portable assay form-factor will be easier
if there is no need to try to miniaturize sample preparation steps. An attempt to
kinetically tune the assay was performed by incubating the target oligonucleotide
with the detection component of the assay. Finally, performance of assay in
detecting purified RNA from virus was assessed with the inherent limit of detection of
the assay preventing positive and specific detection of serotypes.
Subsequent chapters involve work that attempts to address shortcomings of
the assay format. This includes computational modelling of the assay, algorithmic
target selection, and alteration of physical parameters of the assay, including
investigation of signal enrichment techniques
Development of a chemical kinetic model of the assay would aid further
design, as simulation would enable testing of changes without the time and expense
of wet-lab experiments. In addition, an appropriate model would provide
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understanding of the functioning of the system, providing the opportunity to make
principle-based design decisions. In Chapter 4, a model based on mass action
kinetics is developed and modelled using global kinetic optimization software. A
model of all possible reactions is considered and then pared to the minimal kinetic
model consisting of resolvable reactions, reactions that are more likely to contribute
to observable kinetics, and reactions that are consistent with current knowledge.
The model is globally fit to experimental assay data. The objective function of the fit
is a measure of 2 divided by the standard deviation of the data distribution. After
performing global fits of data to the model, a model that is consistent and plausible
with respect to current knowledge is developed. This model characterizes the
nature of the assay function with and without target and thus illuminates the effect of
kinetics on non-specific activation. This model will serve as a tool in further assay
development. Familiarity with the effect that non-specific activation has on kinetics
will guide decisions to further hone the assay. Furthermore, the model can be
modified to consider physical parameters, making it more relevant in the future.
Chapter 4 is also to be submitted for publication after further refinement. My
advisors, Steven W. Graves, Darko Stefanovic, Matthew R. Lakin, Jason Gans,
Andrew P. Shreve, and Ronen Polsky again contributed guidance on experimental
direction and aid with interpretation of data.
Another challenge in development of the assay lies in the selection of target
sequences. Detection relies on the specific binding of a DNA probe to an 18 base
pair target sequence. Since hybridization is determined by Watson-Crick base
pairing, targets can be chosen rationally, rather than empirically. Initial target
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selection had been done using a computational algorithm that rated potential target
sequences using Hamming distance and various thermodynamic parameters. The
resultant target sequences do not appear to be specific, an assessment based on
subsequent alignments. Furthermore, these target sequences do not appear to
detect sequences of a live strain that was used experimentally. Shortcomings in
specificity may have to do with the use of Hamming distance in target choice, as it
doesn’t properly account for base insertions and deletions (indels), misalignments,
and different strand lengths. The poor alignment and the limitations of Hamming
distance suggest the need to implement a new algorithm with a different metric for
improved target search. One such metric is Levenshtein distance, which can score
indels and can manage misalignments and different strand lengths. In Chapter 5,
the outline of a new target search algorithm using Levenshtein distance is discussed
and results for searches performed using this algorithm are presented. As currently
implemented, the algorithm doesn’t consider physical constraints so it might be
expected that the returned targets may not function in wet-lab experiments.
Potential targets may be filtered by use of thermodynamic base-pairing probabilities.
This is done in conjunction with an assessment of target coverage. While the full set
of returned sequences was not assessed due to limited time, a subset of candidate
probes was filtered by pairing probabilities between probes and a subset of potential
targets. For this subset of targets, coverage was maintained, suggesting that some
of the sequences returned from the algorithm will function in situ and cover the
desired target space.
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The kinetic model developed for Chapter 4 is a continuous, deterministic
model. While a continuous treatment of gross quantities of molecules will provide an
accurate predictive model of the reactions, in the regime of low concentrations there
may be deviation from expectation. Often in real-world use of assays, the analyte
may occur at very low concentrations. Despite this, it is desirable to be able to make
positive detections at low concentrations. The presence of analyte at low
concentrations must be distinguished from absence of analyte, and the difference in
numbers of molecules at the limit is discrete in nature. In Chapter 6, a discrete,
stochastic model has been developed that considers interactions at the molecular
scale. Using rate constants derived from continuous models, the substrate-enzyme
reaction and the full assay reaction have been modelled in an attempt to recapitulate
the observed stochasticity in wet-lab data. The variance in the model simulation for
the enzyme-substrate reaction is less than in the wet-lab data, suggesting that there
is substantial experimental error. The variance in the model of the full assay with
target more closely recapitulates that of experiment, while the simulation without
target has much greater variance than the data. Furthermore, stochasticity is much
more evident in the absence of target, suggesting that limit of detection can be
modelled. This model will serve as a stepping stone to a more in-depth hybrid
model for limit of detection that can help verify experimental detection limits.
This work represents an effort to advance the tools and methods of DNA
logic-based pathogen detection. Wet-lab experimental characterization of a
biosensor design was performed with improvements attempted. Both continuous
(deterministic) and discrete (stochastic) models were constructed and provide a
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basis for modelling assay design and characterizing basic attributes of the assay.
The target search algorithm has produced target sequences that may be used for
future iterations of the assay and will physical properties consideration will be
subsequently integrated. Future work will be discussed in Chapter 7 with
preliminary experiments in signal enrichment providing a path forward for physical
design. The DNA logic-based technology is particularly promising for integration into
an assay based on expression profiling or other next generation sequencing (NGS)
format. This work will help pave the way for future point-of-care devices that
integrate the power of NGS and promise of DNA logic.
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Chapter 3.
In vitro evaluation of a DNAzyme-based biosensor for
clinical dengue diagnostics.

3.1 Abstract
Infectious disease has re-emerged in the 21st century as a serious public
health concern that threatens gains from previous eras. Among these new threats,
arboviruses have developed into an endemic presence in the tropics, and the range
of the disease-carrying vectors has now expanded into temperate zones due to
globalization and climate change1,2. Dengue virus is an arbovirus from genus
Flavivirus that can cause serious illness and death, and its clinical course can
depend on the genetic/serologic signature, or serotype, of the infecting virus3.
Specific diagnosis is therefore an important challenge. Given the severity of illness
and potential scarcity of laboratories in endemic regions, it is of particular interest to
find a portable detection solution. Using fundamental DNA molecular logic
technologies, we have developed an isothermal, amplifying, DNA-based assay that
is potentially portable, and have tested it for the first time with genomic RNA
extracted from live dengue virus. The assay was sensitive and specific against a
non-specific DNA background and shown to function in a biological matrix. The
assay has not yet detected extracted viral RNA at concentrations of clinical
significance. Additional isothermal amplification is necessary to achieve the goal of
a portable assay of clinical utility.
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3.2 Introduction
In the last two to three decades, arbovirus-caused illness (virus that is
disseminated by insect vector), has seen both resurgence and new emergence
(depending on whether the virus existed previously or has newly appeared)4.
Among arboviruses, dengue virus is the most widely disseminated, with a range that
encompasses much of the tropics4, and has become the most rapidly spreading,
with an increase in incidence of 30-fold over the last 50 years5. There are 50-100
million cases of dengue fever each year worldwide resulting in 22,000 deaths2,6.
Many areas under threat may not have access to modern laboratory facilities, and
laboratory tests are usually unavailable at the time of diagnosis7, thus it is crucial to
find portable assay solutions that maintain the sensitivity and specificity of laboratory
tests.
The current state of the art for detection techniques of dengue and other
tropical arboviruses comprises molecular (nucleic acid-based) detection, serologic
(protein-based) detection, and viral isolation (culture)3,7. Viral isolation, although
definitive, is rarely performed and is time and resource intensive. Molecular
methods, particularly PCR, have the advantage in terms of assay sensitivity and
specificity. In detection of dengue, PCR is able to achieve a detection limit of 1-50
PFU8, and even limits as low as 7.9 copies/µL9 have been achieved. PCR is
capable of single nucleotide polymorphism (SNP) detection due to the selectivity of
Watson-Crick base-pairing10,11. The specificity of PCR comes in part from the
synergistic effect of two primers, effectively doubling the number of sequences to
match (in comparison to a single target assay). PCR amplifies the region flanked by
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the PCR primers and this gives the method its very low limit of detection (LOD). In
contrast to molecular methods and isolation, which require laboratory facilities,
serologic assays may be portable3,7. Compared with the former, serologic methods
suffer from poorer specificity and may cross-react against similar targets12. The host
immune response targets the presenting capsid proteins of the virus3. These capsid
proteins are fairly well conserved across the four dengue serotypes, and a serologic
method may not be able to distinguish between the serotypes13,14. Indeed, other
flaviviruses may be indistinguishable due to antibodies in serum which cross-react
with capsid proteins7.
DNA molecular logic-based assays are an alternative approach to biosensor
implementation that potentially offer the benefits of both molecular and serologic
tests. Lyophilized DNA is stable for weeks at room temperature and even longer
with certain additives15. Furthermore, the DNA molecular logic-based technologies
discussed here function isothermally. With no need for refrigeration or
thermocycling, a portable, one-pot assay is achievable using molecular logic
technology16.
Our group has previously designed a molecular logic assay for dengue
detection and used it to detect synthetic oligonucleotides corresponding to dengue
targets and discriminate based on serotype of target source17. A more universal
scheme for a DNA-based biosensor that combines various molecular logic
technologies into the unified sensor architecture18 was then developed (see next
section for description of assay architecture). This scheme has been adapted to a
microsphere-based assay for detecting synthetic oligonucleotide analogs for dengue
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targets and has been used to successfully discriminate serotype of the synthetic
oligonucleotides19. This work presents a solution-based implementation of the
unified sensor architecture for detecting dengue targets and discriminating serotype,
and the application of the assay to genomic RNA from live virus.
This assay is isothermal and maintains function in biomatrix, which means
that with minor modifications to the assay, portable, point-of-care testing in far-flung
locales is possible. The implementation is designed to discriminate all four
serotypes of dengue. This will be the first solution-based implementation of the
unified sensor architecture to detect dengue targets. This assay is characterized
with synthetic oligonucleotides (oligos) and is tested with genomic RNA extracted
from live dengue virus. This will be, to our knowledge, the first time that a molecular
logic-based assay has been tested to detect dengue viral RNA, although dengue
RNA has been previously been used as a control in tests for Zika virus16.

pecies
toehold

template strand

eaction

Figure 1: Toehold-mediated strand displacement (TMSD). (A) The oligonucleotide
species in TMSD are the single-stranded input and the bi-molecular gate complex.
The gate complex has a double-stranded region and a single-stranded region called
the “toehold.” The two strands present in the gate complex are the template strand
and the output strand. (B) The toehold is complementary to a portion of the input
strand, so these two regions will readily hybridize (1). Branch migration occurs,
whereby the junction between the input and output strand will progress by random
walk (2). If the reaction system is appropriately biased, the output strand is
ultimately displaced by the input strand dissociating into solution (3).
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3.3 Assay Architecture
The component mechanisms of this architecture are toehold-mediated strand
displacement (TMSD) and catalytic DNA (DNAzymes). In TMSD, a single-stranded
input species displaces another single-stranded output species from a doublestranded gate complex (Figure 1). DNAzymes are single-stranded DNA oligos that
have secondary structure that results in catalytic function. These can catalyze a
number of reactions, but of interest here are DNAzymes with phosphodiesterase
activity. When hybridized with a complementary substrate oligo, the DNAzyme will
catalyze cleavage of a phosphodiester bond on the substrate (Figure 2).

Figure 2: Catalytic DNA (DNAzyme) and Reporter. (A) DNAzyme Mechanism.
DNAzyme hybridizes with its complementary substrate (1). At its active site,
DNAzyme catalyzes cleavage at a phosphodiester bond on the substrate (2). (B)
Use of substrate as Förster Resonance Energy Transfer (FRET) Reporter. A
fluorophore is conjugated to one end of substrate molecule and a quencher to the
other. Substrate is shorter than the FRET distance, enabling the quencher to absorb
energy from the fluorophore, preventing fluorescence. Complementary enzyme
hybridizes with the substrate (1). Cleavage of the substrate occurs, and the
fluorophore-containing product diffuses past the FRET distance, enabling
fluorescence to occur (2).
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These elements are combined into the unified sensor architecture (Figure
3)18. Target identification occurs through Watson-Crick base-pairing between the
gate complex of the assay (Enzyme/Inhibitor complex) and its complementary target
sequence (Target Dengue RNA). This interaction is initiated by binding of the
primary toehold (T1) on the Enzyme/Inhibitor complex to the complementary region
on the Target Dengue RNA (Figure 3A). Through TMSD, the Target Dengue RNA
displaces the remainder of the Detection Module (Figure 3B), exposing the
secondary toehold (T2). Fuel oligo then binds to the secondary toehold and
displaces the remainder of the Reporter Module, releasing the inactive DNAzyme
(Figure 3C). Once free, the DNAzyme can assume its active conformation and
catalyze cleavage of substrate oligo (Figure 3C). The substrate oligo is a FRET
reporter (Figure 2B). Once the substrate is cleaved, the fluorophore is released from
the fluorophore-quencher pair, resulting in the fluorescent signal that is the report of
this system.

Figure 3: Schematic of main reaction steps of dengue assay. (A) Target dengue
RNA binds to primary toehold (T1), displacing detection module. (B) Fuel strand
binds to exposed secondary toehold (T2), displacing inactive DNAzyme. (C) Active
DNAzyme binds and cleaves substrate.
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3.4 Results
Prior to testing of the assay on genomic RNA extracted from live virus, the
assay is characterized by testing with both synthetic and natural DNA to ensure that
it will function as expected. These characterization experiments include testing the
targeting of each serotype gate against its respective synthetic oligo target and
measuring the gate response to background. In addition, each gate was tested with
off-target sequences to confirm specificity. Other testing included confirmation of
enzyme function in bovine serum.
For initial functional assessment, synthetic DNA oligos corresponding to the
targeted sequence of dengue genome were used. Each target sequence DNA oligo
was added to the corresponding assay oligo (serotype 1 synthetic target to serotype
1 assay, etc.). The results of this investigation, shown in Figure 4, confirm that
activation of assay occurs for all four of the synthetic serotype targets.
Non-specific activation, or “leakage,” occurs when the assay activates in the
absence of any target. To assess the amount of leakage, each of the assays were
run without addition of any target (Figure 4). Very low levels of leakage are
observed. Of import, the level of assay activation in the presence of its synthetic
target far exceeded the leakage over time, becoming clearly distinguishable after 1015 minutes of assay run time (Figure 4). The signal from assay run with synthetic
target increased to about 200 times the signal of the raw negative control by about
2.5 hours of run time for assays to serotypes 1, 3, and 4.
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Figure 4: Initial dengue assay characterization. Each assay mixture consisted of a
final concentration of 5 nM fuel, 5 nM enzyme/inhibitor complex, and 250 nM
substrate. Enzyme/inhibitor complex for (A) serotype 1, (B) serotype 2, (C) serotype
3, and (D) serotype 4 was used in the assay mix. There were three experimental
groups for each assay. In the first (Correct Target Activation), 5 nM of synthetic
oligonucleotide target for (A) serotype 1, (B) serotype 2, (C) serotype 3, or (D)
serotype 4 were added. In the second experimental group (Herring Sperm DNA),
heat-denatured herring sperm was added to a concentration of 1 µg/mL. In the third
group (Leakage), no target was added. Correct target signal was distinguishable
from negative control within the first 10-15 minutes and ~200x above negative
control background level ~2.5 hours (A, C, and D), or ~15 hours (B). Herring sperm
DNA reaction was indistinguishable from leakage. Data is the mean of triplicate
data. Error bars are two standard deviations from that mean. All signal data is
background-subtracted and normalized by the maximum signal for correct target
activation.

The sequence specificity of the assay was also tested. Herring sperm DNA
was used as a surrogate for non-dengue nucleic acids that might be found in
sample. Heat-denatured herring sperm DNA was added to each assay (without
adding any target). The non-specific activation signal did not rise appreciably
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compared with the response to correct target and was indistinguishable from the
leakage (Figure 4).
Near the limit of detection, it is difficult to distinguish between the correct
target and other sources of noise (leakage, incorrect target). It is crucial to minimize
leakage in order to improve detection limit. This might be done through modifying
key steps in the overall assay reaction. The assay contains three major kinetic
steps: the binding of the target to the double stranded gate molecule through TMSD
(Figure 3A), the binding of the fuel species to the gate through TMSD (Figure 3B),
and the cleavage of reporter by the DNAzyme (Figure 3C). The middle and last step
are non-specific to a correct activation of the assay but are present in leakage. The
first step is necessary for correct activation. Incubating the target with the assay
components prior to the addition of fuel and substrate means that target-binding
doesn’t have to compete with the non-specific reactions. This might permit better
discrimination between on-target and off-target activation.
To assess effectiveness of target incubation with enzyme-inhibitor complex,
three incubation conditions were performed for each assay. 100 pM of target was
incubated with enzyme-inhibitor complex for 5 hours, 1 hour, and 0 hours. Each of
the four targets were attempted on each assay. After background subtraction and
normalization, each time point for each reaction was classified as positive or
negative depending on whether the signal fell above or below the significance curve
(defined as previously). Grouping into 50-minute intervals, the number of positive
hits is shown in a heat map (Figure 5).
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Figure 5: Positive detections per 50-minute time interval for the assays for serotype
1 (A), serotype 2 (B), serotype 3 (C), and serotype 4 (D). Maximum number of
detections possible is 10 for each interval. Positive detection is determined by a
background-subtracted, normalized signal that lies above the signal level that
indicates significance (determined by IUPAC definition20). 100 pM of target (Each
serotype target attempted separately) was incubated with 5 nM of enzyme-inhibitor
for 0, 1, or 5 hours prior to initiation of reaction by addition of 5 nM fuel and 250 nM
substrate.

Serotype 1 benefits from a 5-hour incubation as positive hits for serotype 1
target become maximal early in the assay run (Figure 5A). There is crosstalk with
the serotype 3 target at five hours, but most other serotypes are negative regardless
of treatment. Serotype 2 also benefits at 1 and 5 hours with the correct target
(Figure 5B), although there is some incorrect activation by serotype 1 target.
Serotype 3 and serotype 4 assays do not show appropriate separation of correct and
incorrect positives regardless of treatment (Figures 4C, 4D). There is significant
variability in results among the samples shown, particularly in the assays for
serotypes 3 and 4. The sample targets are being run at 100 pM which is very close
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to the limit of detection. This regime is likely to result in more inconsistency due to
the proximity of the positive signal to the noise of the blank.

Figure 6: Reaction of DNAzyme with substrate. (A) Reaction in serum. 50 nM of
catalytic DNAzyme and 50 nM of its substrate (whose product is the reporter) were
run in assay buffer with varying amounts of serum. (B) Reaction in Serum (with and
without added zinc). The catalytic DNAzyme and its substrate were run in assay
buffer with either 50% or 98% serum. One sample of 98% serum had zinc added to
a final concentration of 1 mM. Dots are the mean from 3 replicates. Error bar is 2
SD. Background is substrate only (without enzyme). All signal data is backgroundsubtracted.

A challenge in the development of a portable assay is the presence of
biological matrix. The non-viral components need to be removed from the system to
minimize non-specific activation and signal interference. This requires preprocessing of the sample, which typically requires additional apparatus to be used
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prior to running the assay. Alternatively, to detect a virus in blood, the assay needs
to function in the complex environment of the sample biomatrix.
The reporter module of the assay relies on correct function of the reaction of
DNAzyme and substrate. If the sample is contaminated with biological matrix (by
accident or design), the assay will come into contact with matrix components which
may interfere with this reaction, perhaps by chelation of the divalent metal cofactor
required by the enzyme, or degradation of the RNA nucleotide in the substrate.
The substrate/enzyme reaction was run in bovine serum to determine if
serum would inhibit the DNAzyme-substrate interaction. When the reaction was run
under the condition of high serum (98%), it was found to occur at a lower rate
(Figure 6A). In contrast, dilution of the serum in reaction buffer restored the activity
of the reaction (Figure 6A). To test whether this was just an effect of dilution of zinc
ion, a sample of 98% serum had zinc added to restore the concentration present in
reaction buffer (Figure 6B). Added zinc did not appear to restore kinetics of reaction
as the 98% serum with added zinc was not distinguishable from 98% serum without
the supplemented zinc, although added zinc led to higher variability. This suggests
that the assay function in serum will not change with additional supplementation of
zinc, and that serum will require some level of dilution to maximum assay function. It
has been suggested that intracellular divalent cation concentration is too low to
maintain efficient catalysis21–24. This should be less of a concern in serum where
divalent cation levels are higher25 and the continued function of enzyme in serum
here confirms this.
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It is important to confirm if the assay functions for detecting live dengue virus.
Prior to detection of live virus, genomic RNA must be extracted from within the
capsid shell. A spin column with a silica membrane to catch nucleic acids was used
to overcome the problem of contamination with the biological matrix. The remainder
of the matrix is washed away, leaving the assay tested against a background of only
nucleic acid. While the spin column was used to test the assay function here, an
alternative solution would need to be found in order to achieve portability. The spin
column requires use of a centrifuge which requires laboratory facilities. It may be
possible to simply add chaotropes to the reaction buffer to denature the capsid
protein, allowing access to the internal RNA.
Viral RNA was extracted from cultured dengue virus and samples of viral
RNA from each serotype were tested against each serotype-specific assay
separately (Figure 7). Comparing signal against non-specific signal, there was no
significant detection of virus for each of the four serotypes (Figure 7). False positive
detection of serotype 3 occurred in serotype 1 assay (Figure 7A) and of serotype 4
in serotype 2 assay (Figure 7B).
The calculated limit of detection for each of the assays was 120 pM, 72 pM,
63 pM, and 161 pM for serotype 1, 2, 3, and 4 respectively. The estimated viral
genome concentration based on viral titer was 3 pM, 14 pM, 6 pM, and 2 pM for
virus serotypes 1, 2, 3, and 4 respectively. As these virus concentrations fall below
the LOD for each of the corresponding assays, it is not surprising that positive
detection was not achieved for these serotypes. Future iterations of the assay will
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require an amplification method prior to detection. Kinetic optimization and
modelling will also play a role in subsequent assay design.

Figure 7: Assay vs viral sample. Extracted RNA from each serotype of dengue
virus is individually run with each serotype-targeting assay. Shown is raw
fluorescence of viral RNA of each type run with the assays for serotype 1 (A),
serotype 2 (B), serotype 3 (C), or serotype 4 (D). Significance (as determined by the
IUPAC definition20) is plotted in green to show where positive versus negative
determination is made.

3.5 Discussion
This paper presents the implementation and characterization of a dengue
detection bioassay developed from DNA nanotechnology elements. We tested the
ability of the assay to detect synthetic deoxyoligonucleotide targets under different
conditions. We also tested the ability of the assay to detect viral RNA extracted from
live virus. Although dengue has been used previously as a control16, to our
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knowledge this is the first attempt to detect dengue viral RNA using a DNA
molecular logic bioassay.
While the design succeeds in evaluation with synthetic oligo targets, it has not
yet positively detected viral RNA. The greatest challenge to clinical utility is that the
limit of detection of the assay exceeds typical viremia concentrations26,27. This will
be addressed in future designs by using an isothermal detection method such as
LAMP16 or RCA.

3.5.1 Challenge of Addressing Limit of Detection
In assay design, one of the major difficulties is the detection of an analyte at
very low copy number. This can be overcome by including an amplification step
before the assay is performed. Options include rolling circle (RCA), loop-mediated
(LAMP)16, and others. Most of these methods amplify a specific sequence and are
detection schemes themselves. Inclusion of any of these methods might obviate the
need for a subsequent detection method.
The detection system as implemented contains within itself an amplification
method. The second part of the cascade releases the 8-17 DNAzyme which cleaves
a substrate to produce a fluorescent product. As long as the enzyme is efficient, the
signal will be amplified to an arbitrary amount corresponding to the substrate
concentration (Figure 8). Bonaccio et al.28 have shown that there is agreement in
values of k2 and kcat for 8-17 over a range of conditions so the enzyme should be
capable of multiple turnover28, although the length of the substrate-binding flanking
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strands should play a significant role in determining turnover29. In principle, the
dengue assay should therefore be able to amplify signal.

product

Figure 8: Optimal Turnover Example. In the case of an enzyme with optimal
efficiency, amount of product corresponds to amount of substrate, effecting an
amplification of signal. In this idealized case, cleavage of a single substrate
molecule results in a single product (A), whereas cleavage of three substrate
molecules results in the formation of three products with a corresponding increase in
signal (B).

When it came to testing RNA extracted directly from cultured virus, it was not
possible to positively detect the correct serotype of virus presumably because the
concentration of the virus was below the calculated LOD of the assays tested. While
this does not negate the validity of the assay, it presents a challenge in terms of
detection. Titers vary in infected patients depending on the serotype and duration
and type of illness. Titer peaks at 4.5 - 5.5 days post-infection at 107.6 (~6.6 pM) and
can peak as high as 108.5 (~53 pM) for a patient with DHF26,27, values near or below
the limit of detection of the current assay. Viremia ends after about 7 days of
infection meaning that this assay is further limited to this window for virus detection.
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If not measured at the peak titer, concentration of genomic RNA can be as low as
1500 cp/mL (2.5 aM)30 with perhaps a more typical viral load being 258-1560
PFUeq/mL (64 fM – 389 fM)31. Clinical viral titers will tend to fall below the observed
LOD of this assay, so in order to complete the design of a viable assay, it will be
necessary to implement some form of amplification of target prior to the strand
displacement assay. As mentioned, there are a number of options for isothermal
amplification, including rolling circle amplification, loop-mediated isothermal
amplification, and others, so finding an appropriate amplification method that will
work with the interest of portable assay design should be feasible. However, this
presents a further step in design of this assay prior to it becoming fully viable for
clinical application. Subsequent work on this assay will involve testing and
implementation of an isothermal amplification method to discover a method that will
work in the presence of biological matrix. Candidates for isothermal amplification
include RCA and LAMP which has previously been used with a biological matrix 16.
Amplification that functions in the presence of matrix will facilitate design of a
portable assay that can be used at the point of care.

3.5.2 Serotype Specificity
Another major goal of the assay is to distinguish between serotypes of
dengue virus. This is important clinically. Due to antibody-dependent enhancement,
a patient who has been previously infected with one serotype of dengue can develop
an adverse outcome on subsequent infection with another serotype32,33. The rapid
diagnosis of serotype could ensure that the patient receives care commensurate to
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the potential prognosis. Infection with a serotype of dengue initially confers
protection against the other serotypes for a period of 1-3 years34 but if antibody titers
fall to an intermediate level, subsequent dengue infections of a heterologous
serotype can be dangerous and is likely to lead to more severe illness33. This is
likely caused by antibody mediated enhancement35,36. Additionally, the order and
pattern of serotype exposure may be prognostic. In south east Asia, serotype 3
primary infection and secondary infection with serotypes 2, 3, and 4 increase the risk
of severe disease course, wheras secondary infection by serotypes 2 and 3 more
broadly increase risk37. Certain clinical metrics vary by serotype, as individuals with
serotype 2 infection being shown to have the lowest platelet counts as compared
with those infected with serotypes 3 and 438. A variety of medications that target
dengue viral illness are currently in development and while there is an effort to find
drugs that work across serotype, some types work more selectively, in particular,
therapeutic monoclonal antibodies39. It is difficult to differentiate dengue infection
from other febrile illnesses from a clinical assessment, and in many areas where
dengue is endemic there is a clinical presumptive diagnosis of malaria or other
common febrile illness40. It is foremost of importance to be able to differentiate
dengue from other febrile illness. Knowledge of previous infection indicates risk of
worse outcome if the current infection is a heterologous serotype. If this assessment
is made, early oral hydration will be of import for the dengue-infected individual41. It
is particularly important to maintain hydration and to avoid medications such as
paracetamol that will exacerbate hemorrhage.
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Table 1: Representative Smith-Waterman (SW) alignments (using Biopython
PairwiseAligner42) of the dengue biosensor target sequences and the GenBank
sequences corresponding to cultured virus used in the experiment (sources in Table
2). For each alignment, matching bases are indicated by “|”, mismatches are
indicated by “X”, and gaps are indicated with “-”.
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The assay was also evaluated with respect to a non-specific DNA background
or potential activation by off-target sequences. Here the assay did not activate
above baseline, suggesting that the assay was specific to serotype.

3.5.3 Target Sequence Choice
Target sequence choice is arguably the most important aspect of the design.
Choice of target sequence relies on an algorithmic search. Previously, potential
target sequences were 18-base-length sequences compared using the Hamming
distance metric43 (See Methods for details). From the resultant target sequences,
only a single target for each serotype were used. The targets selected using this
method were aligned to the sequences for the dengue strains used in tests for this
assay (Table 1). The targets sequences used in this assay do not appear to be
distinct enough between strains as evidenced by Smith-Waterman alignment (using
Biopython PairwiseAligner42) and furthermore do not appear to be similar enough
with sequences on the correct serotype .
It should be noted that the complete sequences of the organisms used in the
wet-lab experiments do not exist in whole. The exception is for the strain that was
used for the serotype 2 test, Chimeric dengue virus vector p4-D2-CME44. While the
complete sequence exists for this chimera, only a portion of this organism originates
in serotype 2. The capsid, envelope, and pre-membrane genes correspond to the
New Guinea C strain of serotype 2, while the remainder derives from serotype 4.
For the Puerto Rico/1994 serotype 1 strain used in assay tests, sequence
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information exists only for the envelope protein gene45. Strain 3017 was used for
serotype 3 testing. This strain has not been sequenced, but it is a member of group
B subtype III Sri Lanka viruses which had only a 963-base segment of the
polyprotein sequenced46. The accession numbers for the strains used in the
alignment are shown in Table 2. The sample used for serotype 4 has not been
sequenced to our knowledge.

Table 2: Viral genome source sequences used for alignment in Table 1 44–46.

Given that complete sequences for the virus strains used for experimental
validation do not exist, the results of the alignment need to be approached with
some skepticism. Insofar as the results can be taken at face value, they suggest
that the targets chosen for use in this assay do not offer enough coverage of
potential viral candidates as they do not selectively align on the appropriate genome
sequence and they do not offer enough specificity as they align too well on
inappropriate genomes. This suggests that new targets need to be chosen for future
iterations of the assay.
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To this end, we propose a new approach for target search. Candidate targets
must be compared with the entire database of off-target sequences using a metric
that will include not only substitutions, but also insertions and deletions. The
inclusion of gap scoring will improve the scoring of similar sequences that are offset.
In the absence of gap scoring, misaligned sequences might be assigned a higher
distance than might seem evident on inspection.
A second component of target search will include the consideration of
thermodynamics in conjunction with distance metrics. Scoring will be adjusted
based on the state of the system at equilibrium. It is not expected that targets
chosen solely based on distance will be optimal. Potential targets will have different
energies of binding which will affect the favorability of that target when hybridizing
complementary components. A thermodynamic adjustment to the distance-based
score will facilitate discrimination of otherwise similarly scoring targets.

3.5.4 Target Incubation and Assay Kinetic Tuning
Choice of target sequence encompasses other considerations beyond finding
matching sequences. The length of the target sequence is an important concern,
particularly when regarded in conjunction with the toehold length. The hybridization
of target to the entire detection module results in a stable structure, whose stability
depends on length and base composition47–49. In general, the longer the sequence
chosen for the target, the stronger the target interactions with the gate. A long
double-stranded structure is stable, even with a few mismatches, which will drive the
reaction to completion even in the absence of a perfect match. Mismatches will
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have an impact on kinetics of strand displacement and hybridization and TMSD can
be tuned by adjusting the length of the toehold50.
The shorter the sequence, the more likely it will be non-specific. Very short
sequences will be found virtually everywhere due to a lack in complexity resulting in
sequence non-specificity. These limitations indicate that the target must be of an
optimal size, although it may be difficult to determine what that might be.

Table 3: Smith-Waterman alignment of 4 targets to Sero 3 detection module.

In an effort to differentiate correct-target activation from leakage or activation
by other nucleic acid sequences, incubation of target with assay was attempted and
compared with no incubation. While detection of serotypes 1 and 2 was improved to
some extent by this treatment, there was some apparent cross-reactivity with a
single other target each. The assay for serotype 3, on the other hand, appeared to
have cross-reactivity across all of the other targets. Much of the noise in the results
is no doubt due to the target concentrations used near the limit of detection.
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Beyond this, it is difficult to say why some of the assays appear to perform
better with incubation, while with others there is little to no effect. While there
appears to be significant sequence similarity across serotypes for the chosen targets
(Table 2), there is little thermodynamic interaction between the targets and the
toeholds of the opposing enzyme-inhibitor complexes. The non-specificity with
incubation is an effect that is seen primarily in the serotype 3 assay and there are
some areas of sequence similarity between the other serotype targets and the
detection region (Table 3). However, it is important to remember that the rightmost 8
bases of the detection module sequence shown correspond to the toehold region.
The serotype 2 target shows some similarity across both regions of the detection
module making it the most likely leakage candidate of the bunch. Serotype 1 target
and serotype 4 target show sequence similarity primarily in the non-toehold region.
Regardless, NUPACK51,52 analysis of secondary structure of targets and enzymeinhibitor complex does not show stable leakage products occurring.

3.5.5 Assay Function in Biomatrix and Portability
A point-of-care assay should be self-contained and not require sample
preprocessing in a laboratory prior to use. Ideally, the assay should be run directly
on the patient sample. Therefore the assay needs to be capable of functioning in a
biological matrix. We have shown here that the catalytic components of the dengue
bioassay (the enzyme and substrate) continue to function in serum at various
dilutions. While this required some level of dilution of the tested bovine serum, it did
not require supplementation with zinc or other divalent cation in order to restore
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enzyme function. This work suggests that the fundamental components of the
unified sensor architecture assay are robust to biomatrix exposure.
In order for the assay to function as a one-pot assay, it is also necessary to
eliminate the need for an external device to interrogate the sample. The assay
currently relies on a fluorescent report that is excited and probed by an external
fluorimeter. This requires the use of optics and power. Although these components
may conceivably be miniaturized53–55, another approach would enable
implementation of a one-pot assay with no need for implementing a device with
onboard power. The hemin/G-quadruplex DNAzyme can be used as a horseradish
peroxidase analog for a colorimetric report56–58. This would enable assessment by
eye. However, with enough amplification, even fluorescent report can be visualized
by eye16.

3.5.6 Future Work
Future work on the development of this assay will involve the introduction and
testing of an isothermal amplification component to improve the limit of detection to
clinically relevant levels. An algorithm for more robust target discovery will be
composed to improve positive detection while avoiding cross-talk. Combining
distance metrics with thermodynamic considerations into a thorough search of the
existing genomic database for dengue virus will result in better target choice for
future assay design. The result will be a more robust, portable, isothermal assay for
dengue that may be ported to other pathogens. Assays that function at the point of
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care will be instrumental to dealing with the challenges that infectious disease poses
to public health in the current century.

3.6 Conclusion
We have implemented a dengue biosensor using the unified sensor
architecture18. Four modular gate cascades, each targeting a different serotype of
dengue were tested against synthetic oligonucleotides corresponding to the chosen
targets and it was found that gates activated according to the correct serotype target
but not to off-target serotypes or to leakage. The fundamental reporter reaction, the
enzyme-substrate reaction, still functioned in bovine serum, indicating that the assay
reactions will operate in a biological matrix. Finally, the assays were tested against
purified RNA from cultured virus of all four serotypes. Although the assays were not
able to detect virus at clinically relevant levels, this is the first attempt to use a
biomolecular assay to detect genomic RNA from live dengue virus (dengue has
been used as a control previously16). Future work will involve implementation of
isothermal amplification to overcome the current limit of detection. Choice of target
will be improved by implementing a search algorithm that is scored by distance
metric and thermodynamic considerations.

3.7 Methods
Target Design. The unified sensor architecture18 was the underlying
framework of assay design and targets were chosen by the method used for the
microsphere-based assay19. Genome sequences were acquired for each of the four
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serotypes of dengue from the NCBI database. ClustalW alignment 59 was performed
on these sequences to identify regions that were more dissimilar. A target search on
the resultant regions was performed using an algorithm written in Python. The
algorithm split each sequence into all possible 18-mers (oligo of length 18). The 18mers for each sequence were compared with the 18-mers for every other sequence.
Anything containing four ‘C’s or ‘G’s in a row were discarded from consideration.
For each paired comparison of 18-mers, the Hamming distance was determined for
a maximum match length of 8 bases. In addition to distance, each candidate
sequence was run through NUPACK51,52 for output of metrics based on
thermodynamics.

Table 4: Target Sequences Used in Dengue Biosensor.

A number of NUPACK metrics were calculated for each candidate sequence.
Normalized ensemble defect is the average percentage of incorrectly-paired
nucleotides. The unpaired probability is the probability of bases remaining unpaired
at equilibrium. For each target sequence candidate, the average and minimum of
unpaired probability for all bases were determined. The mean free energy of the
structure formed between the acceptor domain (the portion of the target that binds to
the primary toehold) and secondary toehold was considered to ensure that the target
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didn’t bind the secondary toehold (Figure 3). The chosen final targets had a
combination of maximized Hamming distance, minimized normalized ensemble
defect, maximized unpaired probability, and maximized mean free energy of
acceptor-toehold structure (Table 4).
Virus Strains. Dengue viral samples used in this study were obtained from
our collaborator, Kathy Hanley at New Mexico State University. These viral samples
were cultured in passages of both C6/36 mosquito and Vero cells. Collected
samples contain SPG-stabilized supernatant from C6/36 mosquito cells used to
culture individual serotypes of virus in the final passages. These samples were
previously titered at ~107 FFU/mL by fluorescent focus forming assay. Samples of
all four serotypes wer used for the live virus assay.
RNA Extraction. Following manufacturer's instructions, dengue viral RNA
was extracted using a QIAamp Viral

NA Mini Kit (QIAGEN, Valencia, CA). 60 μL of

nuclease-free water was used as the eluent.
Assay Components. DNA was manufactured by IDT DNA (Integrated DNA
Technologies, Inc., Coralville, IA) using solid phase synthesis and shipped
lyophilized. Assay components were mixed in E6 buffer (RNAse-free water with 50
mM HEPES, 1 M NaCl, and 1 mM ZnCl2).
Fluorometry. All assay characterizations and live assay tests were
interrogated by fluorometric measurement. Fluorometry was performed in a 96-well
microplate on a SpectraMax M2e microplate reader (Molecular Devices, Sunnyvale,
CA) using a fluorometric report with excitation of 492 nm, emission of 518 nm and
cut-off filter 515 nm. The final volume per well was 200 μL.
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BasicAssay Characterization with Nucleic Acid Background. Herring sperm
DNA experiments contained fuel, enzyme-inhibitor complex, and target at final
concentrations of 5 nM. Substrate was at a final concentration of 250 nM. Herring
sperm DNA was at a concentration of 1 μg/mL and the stock had been denatured by
heating at 95°C for 3 minutes and cooling by plunging in ice. Background wells
contained only substrate. Leakage, correct-target reaction, and Herring sperm DNA
reaction contained fuel, enzyme-inhibitor (corresponding to each single serotype
test), and substrate. Correct-target reaction contained the target of the appropriate
serotype, whereas the off-target reaction contained Herring sperm DNA. Data for
three replicates of each set of reactions were acquired with a 5-minute interval over
15 hours. For plotting, all samples were background subtracted. The mean and
standard deviation were calculated over the three replicates.
Low Concentration Cross-Talk Characterization. A parallel experiment for
each serotype assay was performed in a 96-well plate. Each experiment consisted
of triplicate negative controls, a set of standards, and a test of assay against each
serotype target oligonucleotide, each in a separate well with a volume of 200 µL.
Enzyme-inhibitor and fuel were used at a concentration of 5 nM for all wells.
Substrate was added to each well for a final concentration of 250 nM. Standards
were four wells which contained appropriate target at either 100 pM, 500 pM, 1 nM,
or 5 nM. Four wells were the test vs each serotype and each contained one of the
serotype oligo targets at 500 pM (or 100 pM for serotype 3). Each well had 20 µL of
nuclease-free water added (to simulate eluent of viral test).

62

Incubation Characterization. Experiments were run in a 96-well plate and four
parallel experiments were run, one for each serotype-specific assay. Each
experiment had three negative control wells, four standard wells, and four
experimental wells (one to test each serotype target). Enzyme-inhibitor and fuel
were in all the wells at 5 nM. Substrate was in all the wells at 250 nM. Standards
had appropriate target oligo added at 100 pM, 500 pM, 1 nM, or 5 nM. The
experimental wells contained target of one of each of the serotype targets at 100
pM. Each well had 20 µL of nuclease-free water added.
Test of Reaction of Enzyme and Substrate in Serum. Enzyme and substrate
were used at final concentrations of 50 nM. Background wells contained only
substrate and reaction wells contained enzyme and substrate. Data was acquired
over 2 hours at 1 minute intervals and performed in triplicate. Means and standard
deviations were calculated from this triplicate data. In the first experiment, the final
reaction mixture contained either 50%, 75%, or 98% of adult bovine serum (Sigma).
The second experiment had three sets of final sample mixtures with one set
containing 50% and the other two sets containing 98% adult bovine serum. One set
of 98% serum samples contained ZnCl2 added to a final concentration of 1 mM, one
set of 98% serum samples contained no additional ZnCl2.
Live Virus Assay. To determine detection of live virus, 50 μL of extracted
RNA from samples of each serotype were added to prepared assay components.
There was a set of standard wells for each serotype assay. The standards had 50
μL of

NAse-free water added. All of the standards and samples contained the

following elements of the assay: Substrate, enzyme-inhibitor complex, and fuel at

63

final concentrations of 5 μM, 1 μM, and 1 μ M, respectively (with enzyme-inhibitor
added just before data acquisition). Negative control had no additional additions.
Triplicate negative control wells were set up for each serotype assay. Four
standards (from each control set) contained target at 100 pM, 500 pM, 1 nM, and 5
nM. Data was acquired with a 5-minute interval for 960 minutes.
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Chapter 4.
Kinetic Characterization of 8-17 DNAzyme and Unified Biosensor
Architecture.

4.1 Abstract
DNA molecular logic technology has shown promise both as an alternative
computational framework and for biodetection. Design of molecular systems uses a
combination of thermodynamics and empiricism. There are limitations to this design
method, so it would be valuable to understand the kinetics of molecular interactions
in the final system. While thermodynamics of DNA interactions is fairly well
understood, kinetics is still largely unexplored.
Presented here is a kinetic characterization of a DNA reaction cascade assay.
A kinetic model has been developed and fitted to data from experimental runs with
synthetic target molecules. Multiple data sets have been acquired which were fit
with a mass-action-based model. The reaction data was acquired first for a core
subset of the overall reaction (enzyme-substrate). Subsequently, the entire reaction
system was fitted, incorporating constants from the initial model.
The model optimization yields rate constants that are plausible and consistent
with existing values in the literature. The enzyme-substrate model has constants
that are adequately constrained. Aspects of the full reaction model are constrained,
but there are still multiple pairwise parameter comparisons that are not constrained.
Future work could introduce experimental constraints to increase confidence of
discovered parameters, but the current model is plausible and reasonable. Using
this model will facilitate future assay design.
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4.2 Introduction
DNA solution-based nanotechnology has shown promise for numerous
important applications, foremost in use as a potential alternative computing solution.
DNA molecular computation is typically implemented as cascades of oligonucleotide
reactions in solution1–7, although surface-based technologies (such as walkers)8–14
are also possible. A particularly promising application of this technology entails
interfacing with biology in the form of a diagnostic, therapeutic, or theranostic device.
Integrating DNA logic cascades into diagnostic bioassays enables the benefits of in
situ computation to be realized within the assay itself.
Current design of DNA logic cascades is a mix of top-down and empirical.
Tools exist for prediction of final structure of molecules based on equilibrium
thermodynamics15,16. While these tools are useful for assessing final structure of
assay components at equilibrium, the impact of kinetics is missed. Without an
understanding of the kinetics, it is not possible to know with conviction how the
reactions will perform once implemented.
While there has been some characterization of the kinetics of aspects of insolution based DNA nanotechnology17–25, there is still a need for more complete
models. This work attempts to address the issue of kinetic modelling and to fill in the
gaps of some of the current knowledge. A model of a DNA molecular logic assay is
constructed using mass action kinetics and optimized, fitting to data from wet lab
runs of the assay. The assay, which targets dengue virus, is based on the unified
sensor architecture previously developed by our group26. This architecture consists

70

of two main components: toehold-mediated strand displacement (TMSD) and
catalytic DNA.

4.2.1 Toehold-mediated Strand Displacement
TMSD is based on a double-stranded gate molecule that has an overhanging
single-stranded region called the toehold (Figure 1). The toehold will interact with a
complementary region on an input strand. The input strand is complementary to the
incumbent strand in the gate molecule. Once the toehold binds the toehold
complementary region on the input strand, the input strand displaces the rest of the
output strand on the gate molecule. This happens in a stochastic manner, but the
system is biased such that at equilibrium the system is stable when the output strand
is displaced and the input strand is totally bound to the incumbent strand.

Figure 1: Toehold-mediated Strand Displacement. See text for description.

Coarse-grained molecular dynamics has been used for modelling kinetics of
strand displacement such as uses of oxDNA for exploration of the effect of
mismatches27. To optimize the kinetics of certain strand-displacement problems,
use has been made of methods such as a remote toehold design28 to improve
discrimination between strands with a single mismatch29. One method of kinetic
investigation used the 3-site-per-nucleotide de Pablo model30,31 combined with
discontinuous molecular dynamics32 to investigate the relationship of temperature
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and concentration to strand displacement33. This work revealed that dimer formation
in strand displacement has kinetics that are more complicated than a simple
bimolecular reaction and that intermediate concentrations and temperature were
ideal.
Sequence-dependent models of strand displacement have been developed
as well. A concurrent displacement model that combines direct dissociation with
sequential branch migration has been fit to single molecule kinetic data showing that
kinetics vary depending on where a mismatch has been placed34.

4.2.2 Catalytic DNA
DNAzymes are single-stranded deoxyoligonucleotides that contain a region
with secondary structure that results in catalytic functionality. Most DNAzymes are
phosphodiesterases that catalyze cleavage or ligation in DNA or RNA molecules, but
they can also catalyze RNA branching, RNA lariat formation, DNA phosphorylation,
DNA adenylation, DNA deglycosylation, DNA oxidative cleavage, thymine dimer
photoreversal, phosphoramidite cleavage, and porphyrin metalation35. In the
phosphodiesterase, the region of secondary structure, or catalytic core, catalyzes
cleavage of a phosphodiester bond between two nucleotides on a complimentary
oligonucleotide (Figure 2A). Contiguous to the catalytic core are two flanking
regions of single-stranded DNA which do not participate in the catalytic activity.
These flanking regions can therefore be programmed with an arbitrary sequence
that that will be complementary to an oligonucleotide of interest. This
complementary oligonucleotide will constitute a specific substrate for the enzyme.
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When paired with the enzyme, the substrate is cleaved by the enzyme’s catalytic
core, resulting in two product molecules (Figure 2A).

Figure 2: Catalytic DNA. (A) DNAzymes cleave a phosphodiester junction on a
complementary oligonucleotide substrate. (B) With a fluorophore and a quencher
conjugated to either end of the substrate, the molecule will serve as a fluorescent
reporter. Due to FRET, the fluorophore is quenched, but once the substrate is
cleaved, the fluorophore can move away and fluoresce.

DNAzymes have been used as amplification or decision-making elements in
molecular computation circuits36–43. Our group uses the 8-17 DNAzyme as an
amplification element to amplify a reporter molecule in an assay26,44,45. Despite
widespread use of the 8-17 DNAzyme36–43,46, kinetic characterization of these
molecules is not yet exhaustive. While rate constants have been derived for a
number of these DNAzymes, these are for limited conditions and there are limited
studies of these molecules (Table 1)23,47–55. This work will further characterize the 817E DNAzyme under different conditions.
The 8-17 enzyme is a class of DNAzyme that contains a short stem-loop and
a curve, and complexes with a divalent metal cation for catalytic function 47. Only a
few nucleotides of this structure are fully conserved in every iteration of the enzyme,
but the general structure is maintained48. Although most early versions of the
enzyme cleaved a phosphodiester bond between an adenosine and a
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deoxyguanosine nucleotide49,56, all combinations of nucleotide junctions are
cleavable using an 8-17 enzyme48,52.
The 8-17E enzyme is one subtype of the 8-17 class of enzymes that cleaves
the adenosine-phosphate-deoxyguanosine (rA-G) junction in a substrate molecule.
Rate constants for a Michaelis-Menten model of the cleavage reaction have been
determined for a subset of conditions (Table 1).

Table 1. Previously determined rate constant values and conditions23,47–49.

An important variable in the kinetics of this cleavage is the length of the
variable flanking region of the enzyme. This is the only region of the enzyme the
changes to which do not affect the basic cleavage reaction but do alter substratebinding conditions and product release conditions.
The assay characterized here has a length of binding arms that may not
correspond to previous kinetic characterizations. Furthermore, the buffer, salt, and
cation concentrations and combination do not correspond to previous conditions
which have been characterized in the past.
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In the design of the dengue assay, the enzyme-substrate reaction is used as
the reporter system. A fluorophore and a quencher molecule are conjugated to
either end of the substrate molecule (Figure 2B). The length of the substrate is
within the FRET (Förster Resonance Energy Transfer) distance of the two molecules
and the quencher thus “quenches” the fluorophore by absorbing energy from the
excited fluorophore. This results in reduced fluorescence of the substrate molecule.
Once cleaved, the two product molecules become free in solution enabling them to
diffuse beyond the FRET distance. The fluorophore is no longer quenched, so when
struck by photons of the appropriate wavelength, fluorescence results. As an
increasing number of substrate molecules are cleaved to product, the number of free
fluorophores increases. The increase of fluorescence in the bulk solution is
monitored using fluorometry, permitting surveillance of the reaction kinetics.

Figure 3. Dengue Bioassay. A target sequence binds to the primary toehold, T1 on
the detection module. The target displaces the remainder of the detection module
region, exposing the secondary toehold, T2. Fuel molecule binds the secondary
toehold and displaces the remainder of the reporter region, releasing the DNAzyme.
DNAzyme assumes active conformation in solution, allowing it to cleave substrate.
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4.2.3 Architecture of the Assay
The bioassay contains various molecular components which interact as a
cascade (Figure 3). Of the interacting constituents, there are three molecule types
present in the assay and there is a fourth molecule, exogenous to the assay, which
should be present to trigger assay activation (Figure 3A). The three endogenous
molecules are the substrate (orange), the fuel (blue), and the enzyme/inhibitor
complex (green, blue, and orange). The exogenous molecule is the target (green)
which is meant to indicate the targeted sequence in the RNA dengue genome, or the
analog DNA oligonucleotide that corresponds to the target sequence.
The dengue assay is intended to follow the mechanism shown in Figure 3. In
the presence of the three reaction components, target should bind to its
complementary toehold (T1) on the detection module (green) of the enzyme/inhibitor
complex (Figure 3A). Through TMSD, the target will displace the remainder of the
detection module, liberating the secondary toehold (T2). Fuel will bind at the
liberated toehold (Figure 3B). Through TMSD, fuel will displace the remainder of the
inactive DNAzyme from the enzyme/inhibitor complex, releasing DNAzyme into
solution (Figure 3C). No longer sequestered, the DNAzyme may assume active
conformation and begin cleaving substrate molecule (Figure 3C).
While the preceding description is the straightforward path which is the
intended mechanism of action, there are a number of sub-steps and alternative
reactions that might occur in this process. This is further discussed in a subsequent
section (4.3: Model). Kinetic characterization of the entire sequence of events is
necessary in order to fully understand the dynamic regime of the system.
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4.2.4 Intent of Model
The purpose of creating the kinetic model is to facilitate design decisions by
having a framework for investigating changes in silico. We may observe how
different outcomes emerge from modifying parameters and use this knowledge to
inform subsequent assay iterations. The model could also be integrated into an
algorithm that autonomously develops the reaction system based on optimized
physical parameters. Automated design has previously been employed in the form
of algorithms to search and design logic gates based on a model57–61.
Tools for automated design of DNA logic networks exist. With visual DSD,
DNA strand-displacement reaction networks may be simulated stochastically (the
Gillespie algorithm62) or a deterministically (the Runge-Kutta-Fehlberg method63)
with design of networks facilitated by using the abstracted formalism of a domainspecific language60,61. While initially confined to strand-displacement reactions with
no secondary structure, recent work has added the capability to model various
topologies thanks to the use of strand graph representation, and enzymatic rules can
be defined in the language64,65. Other examples of kinetic models based on graph
representation for logic network design exist57–59, but are not as versatile as visual
DSD.
While this work doesn’t seek to develop an automated design algorithm, it
does seek to find a kinetic model of the dengue assay reaction and to validate
physical rate parameters with experimental evidence. The kinetic characterizations
made in this work will give a fuller picture of the universal sensor architecture and its

77

use in bioassays. This understanding will enable us to make better design
decisions. With a working model, design decisions that capitalize on kinetic
differences should be possible. Experimenting with these alterations in the context
of the kinetic model will help to elucidate design principles.

4.3 Model
The primary assumption of the model is that the reactants obey mass-action
kinetics. In mass action kinetics the assumption is that the product of concentrations
of reactants is proportional to the rate of change of reaction components. The
contribution of each reaction is linearly summed. The result of each of these rate of
change equations is ordinary differential equations (ODEs) whose parameters are
rate constants. Substitution of seed values into these rate constants and solving the
ODEs gives a model that can then be fit to the existing data.
The dengue assay consists of multiple constituents which, when interacting,
form a reaction network with a variety of possible reaction steps. To form the
minimal model, simplifications of the overall model must be made, removing
reactions which are not resolvable by experiment.
The reaction has at least one subset that can be characterized separately
from the full network. This is the interaction of substrate and enzyme, or the
enzyme-substrate reaction. Based on assumptions of Michaelis-Menten kinetics,
the constituent steps of the enzyme-substrate reaction may be constructed.
Substrate binding occurs first as substrate and enzyme find each other in
solution and hybridize in a diffusion-limited manner (Scheme 1: Rxn 1). Once
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bound, an activated complex must form as the enzyme reduces the transition energy
and substrate becomes activated and primed for the cleavage reaction (Scheme1:
Rxn 2). Following activation, cleavage occurs, and the substrate is divided into two
products, both still bound to enzyme (Scheme 1: Rxn 3). Product release follows
and one or the other of the products must dissociate from the enzyme and fall into
solution. Either product could potentially release first meaning that two alternative
steps could occur at this point (Scheme 1: Rxns 4 and 6). Following release of one
of the products the second product can now be released to solution resulting in
recycling of enzyme and a net release of the two products into solultion (Scheme 1:
Rxns 5 and 7).

Scheme 1. Unminimized Enzyme – Substrate Reaction Scheme.

Reversibility of the reactions must also be determined. All reactions are in
principle reversible, but knowledge about this system can lead to assumptions about
reaction steps that are for all practical purposes irreversible. Catalysis may be
considered irreversible as the enzyme biases the reaction towards completion and
previous literature tends to make this assumption. Product binding and release is
likely reversible given that these are small molecules that are capable of binding due
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to complementarity and likely to be released due to the short length of the binding
sequences. Substrate binding and release is potentially reversible, but release may
seem more unlikely given that the substrate sequence is on the order of 18 bases
long which should be somewhat stable. Literature, however, suggests that the
reaction is in fact reversible with associated non-zero constants to indicate this23,47–
49.

As to the substrate activation, this seems that it is likely to be reversible.
Although we have a complete model of the potential substrate-enzyme

reaction at this point, there have already been some simplifications in the model.
Binding and release of substrate and product are actually multi-step processes as
each pair of complementary bases comes together and potentially come back apart.
Previous work has suggested that this is a fast process and can be approximated by
a single step of binding or release1,3,66.
Reactions that are not resolvable with the experimental apparatus should be
removed from the reaction for simplification. Substrate activation (Scheme 1: Rxn 2)
is the most probable candidate here as there is nothing in the experiment that can
resolve this step from catalysis (Scheme 3: Rxn 3). Thus these two reactions should
be folded together.
Product release can also be simplified on the basis of non-resolvability of
each of the potential product releases. There are two products, P and Q, one of
which has a fluorophore associated (P) and the other which has the quencher
associated (Q). Release of the P product is equivalent to release of the Q product,
as once Q and P are no longer associated, P may then fluoresce (Scheme 1: Rxns
4-7). There is a subtle wrinkle of the additional kinetics of another release step for
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the product P after release of Q which is somewhat hidden in the report of the
reaction. It is potentially a point of debate as to whether product release should be
simplified to one step from four and this is explored further below.

Scheme 2. Minimized Enzyme – Substrate Reaction Scheme.

The resultant minimal model of the enzyme-substrate reaction is shown in
Scheme 2. In this scheme the enzymatic reaction is simplified so that only a single
product is released, and the activated intermediate stage is excluded as there is not
enough experimental resolution for such an intermediate.
Expansion of the model to the full assay is the next step of model formation.
The naïve path that the reaction should follow is binding of target molecule to
double-stranded gate molecule resulting in a target-gate complex (Leftmost reaction
in Scheme 3: EnzInh <=> TargetEnzInh). Subsequently, binding of fuel molecule to
the target-gate complex (TargetEnzInh) results in release of enzyme and formation
of target-fuel-inhibitor complex (Scheme 3: TargetEnzInh <=> Enzyme). The free
enzyme at this point is now free to bind substrate and the enzyme-substrate model
already derived would occur at this point. The full, unreduced enzyme-substrate
reaction is shown (Scheme 3: upper right branch).
There are a number of alternative pathways that must be considered,
however. One possible (though quite unlikely) pathway is spontaneous dissociation
of enzyme-inhibitor complex into free enzyme and inhibitor (Scheme2: EnzInh <=>
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Enzyme). Once free, the enzyme will then follow the enzyme-substrate pathway
(Scheme 3: upper right branch).

Scheme 3: Full Reaction Scheme. Description in body. Dagger indicates activated
intermediate.

Another possibility is that the fuel strand binds to the gate molecule, freeing
up the active part of the enzyme (Scheme 3: EnzInh <=> FuelEnzInh). As
previously mentioned, the design of the system intends that the secondary toehold is
sequestered in a loop until the target binds the detection module, opening the loop to
reception of the fuel strand. It is suspected that the loop is not fully sequestered,
and the fuel strand is able to bind to the secondary toehold, resulting in
displacement of the active portion of the enzyme. Once the active portion of the
enzyme is available, the cleavage of substrate could then occur, resulting in an
alternative “leakage” pathway that mirrors the same steps as the regular enzymesubstrate reaction (Lower right branch of Scheme 3). This alternative pathway may
be simplified in the same manner as the enzyme-substrate reaction, with enzyme
replaced by fuel-inhibitor-enzyme complex. It is also possible that the enzyme “falls
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off” the fuel-inhibitor-enzyme complex, freeing the enzyme to follow the enzymesubstrate pathway (Scheme 3: FuelEnzInh <=> Enzyme with byproduct
FuelInhibitor).

Scheme 4: Minimal Kinetic Model

It is also possible that target bind to the fuel-inhibitor-enzyme complex at any
point during the alternative pathway, shuttling the enzyme over to the regular
enzyme-substrate pathway (Scheme 3: paths from lower right branch to upper right
branch). Since the leakage pathway is expected to absorb only a small quantity of
the reaction components, there will be very low amounts of reactants to follow these
target-binding pathways. With low levels of target-shuttling occurring, these
reactions will constitute a very small portion of the final mechanism. These reaction
steps are therefore unlikely to contribute much to the final mechanism and the model
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may be simplified by removing these steps. This gives us the final minimal kinetic
model to be used for modelling the experiment (Scheme 4).
The minimal kinetic model contains the reactions that are most likely to
contribute to the model, to be observable, or to be resolvable with experiment.
Additionally, the removal of reactions simplifies the model, making the problem of
alignment with wet-lab data more tractable. The reactions remaining are those
corresponding to interactions with target molecule (reactions 1 and 2 from Scheme
4), the enzyme-substrate reaction (reactions 9, 10, and 11), and the leakage
reactions (the remainder). The paths most characteristic of the leakage reactions
are the primary leakage pathway (reactions 3, 6, 7, and 8), and in particular, the
catalytic leakage pathway (reactions 6, 7, and 8).

4.4 Method
4.4.1 Wet-lab Experiments
The dengue assay was based on the basic unified sensor architecture 26
(Figure 3) with four separate iterations. Each iteration had a separately designed
detection module using a genome target sequence chosen from one of four dengue
serotype sequences. Sequences were chosen using a search algorithm written in
Python. The algorithm split each serotype sequence into all possible 18-mers (18base lengths) and compare these with all possible 18-mers from the other serotypes.
Anything containing four ‘C’s or ‘G’s in a row were discarded from consideration.
For each paired comparison of 18-mers, the Hamming distance was determined.
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The DNA used in the physical experiments was manufactured by IDT DNA
(Integrated DNA Technologies, Inc., Coralville, IA) using solid phase synthesis and
shipped lyophilized. Assay components were resuspended in RNAse-free water and
subsequently serially diluted using buffer containing 50 mM HEPES, 1 M NaCl, and
1 mM ZnCl2 in RNAse-free water.
Enzyme-substrate reaction experiments were run in triplicate. Each replicate
had the following experimental groups (each in an individual well on a 96-well plate):
background, 5nM enzyme, 25 nM enzyme, and 125 nM enzyme. Each group had
substrate at a final concentration of 50 nM. Enzyme concentration corresponded to
that already mentioned for each experimental group with background wells
containing no enzyme. The final volume in the wells was 200 µL using the
previously mentioned buffer
For the full reaction, experiments were performed in triplicate and each had
the following experimental groups in separate wells on a 96-well plate: background,
leakage, and experiment with 5 nM target. Leakage and experiment had enzymeinihibitor complex and fuel at a final concentration in the well of 5nM. All wells had
substrate at a final concentration of 50 nM. The 5 nM experimental well additionally
had target oligonucleotide at 5 nM. The wells were filled to a final volume of 200 µL
using the above-mentioned buffer.
The microplate was placed on a SpectraMax M2e microplate reader
(Molecular Devices, Sunnyvale, CA), and using excitation of 492 nm, emission of
518 nm and cut-off filter 515 nm, fluorometric data was acquired.
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4.4.2 Simulations and Fitting
KINTEK Global Kinetic Explorer software67,68 is used for optimization and
fitting. Fitting is performed by optimizing the chi-square error. Optimizing chi-square
results in a model that is minimized to a local optimum. To help avoid local minima,
a fit can be performed globally, meaning that multiple data sets are fit at once.
The simulations were fit to data acquired in the wet-lab. This data was
background-subtracted (mean of background) and normalized to a linear fit to the
values of last 20 time points of the highest concentration sample.
Model parameters are explored using MATLAB and KINTEK67,68. The model
is adjusted by varying parameters, investigating sensitivity and analyzing
constraints. Parameter space is explored by varying some parameters while others
are fixed to see how the fit is altered. For example, using MATLAB ODE solvers to
solve for the model in Scheme 2, the rate constant k3 is varied from 0 to 500, using a
variety of potential values, and it is seen that a value of 1.000 results in the closest fit
to the data (Figure 4A). Sensitivity analysis provides a means to see at which points
in the reaction that variation of parameters makes the most difference. This is
plotted as the sensitivity for each parameter over time in the Scheme 2 model
(Figure 4B). Using KINTEK software67,68, bivariate parameter space is explored
against a goodness of fit metric (𝜒2/𝜒2min). The parameters k1 and k-1 are varied with
respect to each other and the resultant goodness of fit (gof) plotted (Figure 4C). It
can be seen that there is a consistent ratio of parameters which give the minimum
gof, but that this ratio encompasses a large range of values of k 1 and k-1 (The
appearance of multiple peaks along this line is an artifact of the grid size). This ratio
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indicates a consistent equilibrium constant, but the model must be constrained
further in order for the model to meaningful.

a

b

c

Figure 4. Exploration of parameter space is performed by (A) parameter variation,
(B) sensitivity analysis, (C) and optimization of a goodness of fit parameter with
respect to variation of two rate parameters. Plotted in KINTEK67,68.

4.5 Results
The enzyme-substrate reaction was acquired experimentally in triplicate with
three different concentrations of enzyme. Enzyme was used at concentrations of 5
nM, 25 nM, and 125 nM. Substrate was used at 50 nM concentration. This allowed
an exploration of a range of enzyme concentrations with respect to a constant
substrate concentration, allowing simultaneous comparison of excess substrate and
excess enzyme.
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Figure 5. Fit of data to enzyme-substrate model. Model of reactions fit to data from
enzyme-substrate reactions run in triplicate with enzyme at 5 nM, 25 nM, and 125
nM and substrate at 50 nM. Derived rate and goodness-of-fit parameters are
shown.

A global fit was performed with triplicate of each of these three
concentrations. The resultant chi-square of the fit is 4335.98 and the chi-square to
degrees of freedom ratio is 16.3622. This is indicative of a reasonable fit and chi-byeye suggests a reasonable fit for the most part. Residuals at early time points are a
little biased in one direction indicating a sub-optimal fit, however the residuals are
fairly well distributed in aggregate. Resultant rate constants are shown in Figure 5.
These values are commensurate with existing literature values and plausible based
on known mechanisms.
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The model that this fit is based on includes the reduced product release
mechanism. The question remains whether a better fit would be achievable using
the full product release mechanism of two products that are released. In this case
there does not seem to be much to gain from that addition, and it is desirable to
minimize the number of steps in the model to resolvable steps and unnecessary
steps that do not add much to the mechanism.
To assess how constrained the model is, we must look at the error space of
the model. Looking at the parameter space of substrate binding/release and
substrate cleavage, it can be seen that substrate cleavage is constrained with
respect to the other parameters, even though these parameters are not constrained
in return (Figure 6). Substrate binding appears to be constrained with respect to
substrate release, although the reverse does not appear to be true. Fixing substrate
cleavage merely confirms the relationship of substrate binding/release.
Furthermore, standard errors of substrate binding and cleavage are 0.007 and 0.04
respectively, which is reasonable given the rate constants of these steps. Despite
substrate release being unconstrained, it is possible that given the stability of binding
of substrate to the enzyme due to the length of stable base-pairing, a very low to
zero rate constant might be reasonable. So, despite the fact that there is a lot of
potential play to that value, it is reasonable to assume that we can eventually
approximate it as having a low value in subsequent models if the amount of play
remains.
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Figure 6: Constraint of substrate binding/release and catalysis. Pairwise chi-square
comparisons of binding (k+9) and release (k-9), binding and catalysis (k+10), and
release and catalysis. Catalysis is constrained with respect to the other two
constants. Binding is constrained with respect to release. Goodness of fit for this
comparison: Sigma: 0.024, Chi2: 4341.2, Chi2/DoF: 16.4. Rate constants
correspond to those in Scheme 4. Plotted in KINTEK67,68.

Substrate binding and cleavage can now be held constant in subsequent
models as these values are within a global minimum of chi-square. Looking at the
constraint in a comparison between product release and binding and substrate
release confirms the unbounded nature of substrate release, but suggests that
product binding and release are somewhat constrained with respect to each other
(Figure 7).
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Figure 7: Constraint of substrate binding/release. Pairwise normalized chi-square
comparison of substrate binding (k+9) and substrate release (k-9). Goodness of fit
for this comparison: Sigma: 0.024, Chi2: 4341.2, Chi2/DoF: 16.4. Rate constants
correspond to those in Scheme 4. Plotted in KINTEK67,68.

The final comparisons in the enzyme-substrate model involve performing
comparisons of the remaining unconstrained value, substrate release, and the
remaining steps in the enzyme-substrate model, product binding/release (Figure 8).
Substrate release remains unconstrained with respect to the other constants.
Product release and binding appear to be constrained with respect to each other.
This suggests that the enzyme-substrate model appears to be largely valid with
reasonable parameters. The substrate release step appears to be the least
constrained of the fitted reactions.
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Figure 8: Constraint of substrate release and product binding/release. Pairwise
normalized chi-square comparison for substrate release (k-9) and product release
(k+11), substrate release and product binding (k-11), and product binding and
release. Goodness of fit for this comparison: Sigma: 0.024, Chi2: 4341.2,
Chi2/DoF: 16.4. Rate constants correspond to those in Scheme 4. Plotted in
KINTEK67,68.

The result of the fitting of the enzyme-substrate model to the data suggests
that rate constants for the model are reasonable. These values will be held fixed in
the subsequent steps.
Subsequently, modelling of the “leakage” reaction is performed. Fitting the
model of the leakage reaction to the data from a leakage reaction results in a fit with
chi-square of 0.0124239 and a chi-square/DoF of 1.4 x 10-5 which indicates that the
fit is quite good (Figure 9). Chi-by-eye suggests a very good fit as well, but the
residuals oscillate about zero for early time points suggesting systematic deviation
from the model. These oscillations are small and in aggregate the residuals are
fairly well distributed around zero. The resultant rate constants are commensurate
with literature where values exist.
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Figure 9: Fit of data to leakage model. Model of leakage reactions fit to data from
assay run with no target. Derived rate and goodness-of-fit parameters are shown.
Previously-derived parameters held constant for fit. Reactions correspond to those
shown in Scheme 4.

The parts of the leakage model relating to the alternative enzymatic reactions
bear investigation. A pairwise comparison of leakage product binding and release
shows a linear relationship of error (Figure 10). This indicates that these constants
should be paired in a ratiometric manner, indicating an equilibrium constant
relationship.
Affixing product binding/release as an equilibrium constant, the constraint of
all of the reactions involved in the alternative catalytic pathway are analyzed. A
pairwise comparison of chi-square for all substrate binding/release and catalysis is
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made with product binding and release pinned (Figure 11). The result for all
pairwise comparisons shows that there is no constraint for any of the pairwise
comparisons. We must compare the values we have to literature instead. At this
point, the model is reasonable for approximating the mechanism of reaction as
understood. The core of the mechanism, the enzyme-substrate reaction is
particularly well constrained and reasonable.

Figure 10: Constraint of leakage pathway product binding/release. Pairwise
comparison of chi-square for product release (k+8) and product binding (k-8).
Goodness of fit for this comparison: Sigma: 0.004, Chi2: 0.012. Rate constants
correspond to those in Scheme 4. Plotted in KINTEK67,68.
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Figure 11: Constraint of leakage pathway enzyme-substrate reaction. Pairwise
comparison of substrate binding (k+6) and release (k-6), substrate binding and
catalysis (k+7), substrate release and catalysis, substrate binding and product
binding/release (k+8), substrate release and product binding/release, and catalysis
and product binding/release. Goodness of fit for this comparison: Sigma: 0.004,
Chi2: 0.01. Rate constants correspond to those in Scheme 4. Plotted in
KINTEK67,68.

Including the target binding/release and subsequent displacement of fuel
leads to the full model in the presence of appropriate target. Performing a global fit
of both leakage and 5 nM target leads to a fit with a chi-square of 1340.37 and a chisquare/DoF of 1.21851, indicative of a particularly good fit (Figure 12). Chi-by-eye
shows a very good fit and the residuals, in aggregate, are very well distributed
around the zero line.

95

Figure 12: Fit of data to full model. Model of reactions fit to data from assay run
with no target and assay run with 5 nM synthetic oligonucleotide target. Derived rate
and goodness-of-fit parameters are shown. Previously-derived parameters held
constant for fit. Reactions fit correspond to those shown in Scheme 4.

As binding of either target or fuel to the gate complex produces a long doublestranded region of DNA, either release of target or of fuel would be very unfavorable,
so it can be assumed that target binding and fuel binding are irreversible. Fitting of
forward rate constants gives 0.0104 for target binding and 0.022 for fuel binding.
Pairwise comparison of these two rates shows that they are somewhat constrained
with respect to each other (Figure 13).
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Figure 13: Constraint of target-interaction reactions. Pairwise chi-square
comparison of target-binding (k+1) and fuel-binding to target-enzyme-inhibitor
complex (k+2). Goodness of fit for this comparison: Sigma: 0.004, Chi2: 1340.4,
Chi2/DoF: 1.22. Rate constants correspond to those in Scheme 4. Plotted in
KINTEK67,68.

Table 2. Rate constants derived from kinetic model fitting and optimization.
Reaction numbers correspond to rate constant subscript numbers in Scheme 4.
First order rate constants are in units of min-1 and second order rate constants are in
units of nM-1·min-1.
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4.6 Discussion
The result of this work is a kinetic model for the dengue viral assay with
parameters that have been shown to be consistent to literature values, where they
exist. The model contains 22 potential reaction directions (11 pairs of reactions with
forward and backward direction). Of these reactions, 5 can be assumed to be
irreversible, simplifying the model by setting the reverse rate of these reactions to 0.
The model, thus constrained, contains 17 parameters to be modelled. Four of these
rate constants apply to the enzyme substrate reaction and can be determined with
high confidence in separate assays of the enzyme-substrate reaction. Fixing these
constants results in 12 that need to be fit to the model. Holding most of the values
constant and performing a pairwise comparison of the two reactions that involve
target show that these rate constants are constrained with respect to each other.
This gives confidence in the values for that the reactions that involve target.
However, subsequent analysis shows that most of the remaining parameters are not
well constrained. Limiting these parameters is not as straightforward as there are no
clear assumptions that can be made in order to fix values. Part of the reason for this
is that the remainder of the model is not easy to separate into meaningful units. The
catalytic leakage pathway has two reactions that can be paired as an equilibrium
constant, but the remainder of the catalytic leakage path shows little to no constraint.
Confidence in the current model is based on congruence with literature data.
The parameter values that have survived rounds of optimization are near expected
numbers, and so are believable as plausible parameters.
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The enzyme-substrate reaction is the easiest to compare with literature as
there has been characterization of DNAzymes by various groups23,47–49. Of
particular interest here are the rate constants that have been determined for 8-17
under various conditions and for various subtypes (Table 1) and these values may
be compared with those derived from the model fitting and optimization performed
here (Table 2). The binding of substrate to enzyme (Scheme 4: k9) is expected to be
in the range23 of 107 to 5×107 M-1·min-1 and the value reached in the model is 0.05
nM-1·min-1 or 5×107 M-1·min-1. Substrate release (Scheme 4: k-9) is expected23 to be
in the range of 0.005 to 0.04 min-1 and the value in the model is 0.03 min-1.
Catalysis of substrate (Scheme 4: k10) has been shown to be in the range23 of 0.01
to 0.4 min-1 while the model value is derived to be 1.43 min-1. At first blush, this
seems to be an order of magnitude too high, but the literature values mentioned thus
far are from 8-17cb whereas the enzyme used in the dengue assay and
characterization here is 8-17E. Values for catalysis rate constants have been shown
to be as high as 1.7, 1.8, or 3.1 min-1 for 8-17E47–49. While these values are single
turnover numbers, it is not unreasonable to assume that the catalysis values could
be in this range for higher substrate concentrations.
Most of the remaining rate constants that can be compared with literature are
bimolecular hybridization that are essentially diffusion-limited. This includes targetbinding (k1), fuel-binding (k2 and k3), binding of, and product-binding (k-11 and k-8).
These values are 0.01, 0.02, 0.04, 0.07, and 0.07 nM-1·min-1 or 1×107 to 7×107 M1·min-1.

DNA diffusing in high salt (the buffer used is 1 M NaCl) should be on the
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order of 107 to 107 M-1·min-1 so these second order diffusion constants are
consistent with expected rates25,69–71.
Further constraining the model would require different experimental apparatus
or technique. Though it is preferable to have a model that is better constrained, it
suffices to have values that satisfy a fit to data and correspond to known physical
parameters and literature rate constants. Future work will involve finding better
experimental resolution of the reaction steps in the leakage pathway. One
alternative would be to use stopped flow experiments which would allow for
improved time resolution. Using the intercalator ethidium bromide for report of DNA
interactions would allow interrogation of steps with finer grain detail.
It will be necessary to better understand the kinetic outcome of sequencespecific alterations of the assay in order to use the model to help with design. While
the thermodynamics of nucleic acid interactions is well characterized72,73, the kinetic
results of any particular design consideration are less apparent. With a kinetic
model of the reaction scheme, looking at how changes in the scheme result in
alterations of the previously determined rate parameters can inform future models.
As an example of sequence-specific change in reaction kinetics, the dengue assay
was redesigned in the following manner. The sequence of the secondary toehold
(Figure 14A: blue sequence) was substituted with the secondary toehold sequence
of a competing assay (Figure 14B). The change in reaction kinetics can be
appreciated in Figure 14C. While the expected assay activation (solid lines) does
not appreciable change, the leakage (dotted lines) shows markedly different kinetics
in the three experimental systems assayed. The R2-GT assay shows the lowest
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rate of leakage, while the systems with and without toehold replacement show
higher leakage. Compared with each other, these two systems show differences in
the biphasic kinetics. A better understanding of these kinetics could help in future
assay design.

C

Figure 14. Sequence of Fuel/Inhibitor complex from two different systems: Old
Sero2 and R2-GT (A and B respectively) and the change to result in the New Sero2
complex (green arrow). Resultant kinetic trace of these three systems over time is
shown in C.

Previously designs have been evaluated using empirical determinations.
Base mismatches will alter the kinetics of reaction steps, but it can be difficult to tell
how much or little mismatches will affect the kinetics. Optimizing decisions in design
will result in slowing down some reactions and speeding others up. In managing the
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leakage of the system, mismatches can be (and have been) introduced into the
secondary toehold26. This induces a less favorable state of binding between the
secondary toehold on the gate and the toehold-binding region on the fuel strand.
The result is a slower reaction rate for the binding of fuel to the secondary toehold
and the displacement of the enzyme from the gate molecule. This result is slower
release of enzyme under for both leakage and non-leakage pathways.
It would be desirable to have a kinetic model that is generalizable to other
reaction systems and technologies. For this work, a particular iteration of the unified
sensor architecture was applied to a singular application in the detection of dengue
virus. The choice in assay design used for the kinetic model leaves a number of
other DNA nanotechnology-based solutions unexplored. Surface-based kinetics is
not considered here, as in the case of strand-displacement based cascades affixed
to a surface or DNA walkers. Certain broad cases of solution-based interaction are
not considered here, such as tile-based reactions. Within the realm of solutionbased cascades using TMSD and/or DNAzymes, this implementation represents a
specific set of interactions. Thus, there are limitations to the generalizability of this
model. Nevertheless, this work represents a step toward better understanding of
reaction systems of this kind.

4.7 Conclusion
Improved understanding of the kinetics and thermodynamics of DNA-based
reactions and assays will be of use for future designs. The problem will become
more complex as in vivo applications of DNA nanotechnology grow. In design of
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theranostics or DNA circuits that will interact with the human genome or genome
products it will be useful to be able to predict how accessible these components are
for interaction with a theranostic. There is already work to characterize
thermodynamic properties of components of the human genome 74 and this
information will help to determine structure and accessibility of in vivo targets to
manipulation by DNA circuitry. Additional work to provide methods to characterize
kinetics in living cells are also being developed75. Our model will contribute to this
increasing landscape of kinetic models. Taken together, these models will provide a
framework for the future design of diagnostics and theranostics that target nucleic
acid markers for human health applications.
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Chapter 5.
Algorithm for Target Selection in Nucleic Acid Sequence-based Assays.

5.1 Abstract
Choosing an appropriate target for a nucleic acid strand-displacement based
assay is a non-trivial problem that must balance sequence specificity,
thermodynamics of strand interactions and utility of the resultant assay. While the
dengue assay is intended to be serotype-specific, initial results with RNA extracted
from live virus suggested that it was non-specific. In addition, the initial targets were
not chosen with optimal coverage of serotype considered. To address the difficulties
with the initial target choice, we seek in this work to develop a target search
algorithm to choose new targets to update the assay. The developed algorithm will
use Levenshtein distance as a comparison metric and will explore the effect of query
and subject word length and threshold for distance metric. It is shown that more
target candidates are returned at shorter word length and lower distance threshold.
In thermodynamic assessments, probe candidates resulting from the algorithm show
favorable binding probabilities to the dengue genome despite distance-based
discovery.

5.2 Introduction
While the unified sensor architecture1 assay for dengue was designed to
differentiate between serotypes, preliminary results with viral RNA isolated from live
virus suggested that it was non-specific with respect to serotype. Although false
negatives are likely with RNA viruses2, this assay had to contend with the additional
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problem of differentiating genetically similar serotypes, potentially resulting in false
positives. As opposed to a protein-based assay which works solely on the basis of
intermolecular affinities, this and other molecular assays respond to sequence
information. The target sequence must be carefully chosen if specificity is to be
obtained. Finding an appropriate target is facilitated by use of an automated
algorithm. Choice of target must be constrained by sequence, thermodynamics, and
specific assay considerations.

Figure 1. Probability of a 20-base DNA strand (AACTGTAAGAAGAAGAATTT)
binding to its complement ( AAATTCTTCTTCTTACAGTT) and to a complement with
one base mismatch (AAATTCTTCGTCTTACAGTT). Probability of each base
binding given by color with key shown in colorbar. With one mismatch, both strands
are still likely to hybridize, despite the mismatch being unpaired. Probabilities and
graphics are output from NUPACK3,4 software.

The challenge is experimental discrimination of two different sequences with
the starting point of an alphabet of four letters, and a limiting length of each
sequence. In principle, distinguishing two sequences can be done with a difference
of one letter, however there are two real-world complicating factors. One is the
thermodynamics of DNA hybridization. The second is that each serotype comprises
a distribution of related-but-different genomes.
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It is not thermodynamically favorable for a single base to form hydrogenbonds with a non-complementary base. However, with two potentially
complementary strands that differ by only a base, the remainder of bases are
complementary. It will be favorable for these to pair based on Watson-Crick base
pairing, but unfavorable for non-Watson-Crick bases to pair. If the number of
matching pairs greatly outnumber the unmatching pairs, the two strands will be
stable overall (Figure 1). For example, for a 20-mer, one base-pair mismatch will not
result in a non-binding pair of DNA strands. In essence, due to physical constraints,
this assay cannot detect single nucleotide polymorphisms (SNPs), though there are
potential solutions to SNP detection through hybridization5. Otherwise, the number
of mismatches limits specificity of detection, but this varies with respect to the length
of the detection region. The effects of mismatches on nucleic acid binding have
been well studied through the nearest neighbor model and the work of John
SantaLucia and are extensively in modelling and nucleic acid sequence design3,4,6–9.
The other complicating factor is that each serotype does not contain a single,
perfectly conserved, genomic sequence, but rather there are many related, but
different, genomes that belong to the same serotype. Being able to distinguish a
sequence in one genotype from one serotype from a single genotype in another
serotype does not mean that this chosen sequence will be present in every genotype
belonging to the serotype. Viruses evolve, which mean genome sequences
gradually diverge from each other leading to more heterogeneity in any particular
chosen part of the genome.
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There are a number of existing sequence-based alignment tools, such as
BLAST10, which is a local alignment tool that has a number of flavors. At its most
basic, it divides a database into words, scans for matching hits, then extends based
on a maximal segment pair. Both global and local alignments have a basis for
scoring similarity such as Needleman-Wunsch11 (global) or Smith-Waterman12
(local). Compared words are scored based on insertions, deletions, mismatches,
and gaps. Alignment-based tools tend to give results based on similarity and are
generally aimed at establishing taxonomic relationships between regions of interest.
When choosing a target for an assay, it is important that the assay oligo bind all of
its intended targets but does not bind any unintended target. PCR primer search
tools and PCR primer design tools may help with target search and assay design.
With important exceptions2,13,14, these are based on distance-based search and only
search single genomes13. Assay design tools such as Primer3 and ProSig, and
assay search tools such as Genomorama and ThermonucleotideBLAST use
thermodynamic parameters for scoring of matches2,13,14.
With the aforementioned complicating factors taken into consideration, the
question is, what are the limits in the ability of an assay based on target DNA
sequence for detection and differentiation to be able to both positively detect a
serotype (population) and successfully distinguish it from another serotype or
population of interest?
In this work we explore distance-based search and characterize the ability of
a distance-based algorithm to find targets for dengue virus that are serotype specific.
The algorithm is designed to search for a target sequence within one serotype which
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also distinguishes from another serotype. The comparison will be distance-based
initially, but thermodynamic elements eventually will be added.

5.3 Methods
The sequence databases used in target searches came from the NCBI
nucleotide database15. A search was made on October 12th, 2017 in the nucleotide
database for each dengue virus serotype for matches between 10 and 15 kilobases,
excluding patents. The search returned 1862, 1421, 932, and 228 sequences for
each serotype (1-4 respectively), which were downloaded as FASTA format files and
used as the database for that serotype. Each serotype database was used as either
target or background database in each run of the search algorithm.
The algorithm is written in Python and run on a hyperthreaded 48-core Intel®
Xeon® CPU E5-2680 v3 running at 2.50GHz. The algorithm takes advantage of
multiprocessing by splitting the inputs and conducting multiple parallel searches
(Figure 2). The algorithm begins by extracting a dictionary of words from the query
database. All possible words of a given length are found for each genome sequence
in the query database. This becomes the query word dictionary. Similarly, all
possible words of the same length are extracted from the subject database, forming
the subject word dictionary. The query word dictionary is then split into multiple
chunks for parallelization. Multiple comparisons are then made with each subset of
the query word dictionary and the entire subject word dictionary. Every word in each
query set is compared with every word in each subject set.
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Comparing sequences requires a metric to be used for differentiation of two
sequences. In this case Levenshtein distance has been chosen. Levenshtein
distance (LD) is the number of single letter differences between two words. In the
case of a DNA sequence, each insertion, deletion, or mismatch will increase the
score by one. The total score equals the number of single letter differences.
Each comparison will result in either a match or a non-match. An LD score is
computed for each comparison. If the calculated LD score falls below a
predetermined threshold, this constitutes a match. Query words that match with
words in the subject database are discarded, while query words that don’t match
with the subject database are retained. Essentially a set difference between the
query database and subject database is produced.
Following the comparisons, all the query word subsets are rejoined into a
single query word dictionary. The result is a database of query words that differ from
the subject database words by an LD score of at least the threshold value. If the
threshold value is sufficiently high, then the remaining words will be appropriate
target candidates that will distinguish the query serotype from the subject serotype.
The target sequence candidates may then be assessed by means of other metrics.
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Figure 2. Schematic of target search algorithm. The query database (which
comprises the genome sequences of the serotype for which we are trying to find a
nucleic acid probe) is used to extract all possible words of a certain length. This
population of words is divided into chunks for parallelization. The background
database (which comprises the genome sequences of the serotype from which we
want to distinguish a match) has all possible words of length k extracted. The
background words are then compared with the query words using the Levenshtein
distance metric. Query words from comparisons resulting in a distance that falls
below the threshold are discarded resulting in increased speed. Surviving query
words serve as candidate probe targets.

Two aspects of target search that are, as of yet, unaddressed by the
algorithm are thermodynamic assessment of target candidates, and assessment of
the coverage of query genomes by the target candidates. Thermodynamics needs
to be considered in order to determine how the candidate will behave in the physical
implementation. Coverage must be evaluated to determine if the candidate targets
adequately detect enough genotypes for each intended serotype.
The candidates resulting from the target search were chosen based on edit
distance. While distance is useful for differentiating sequences, the physical
interactions of DNA molecules has not been represented. It is instructive to learn
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how the candidate sequences will function in solution, and so it is important to
conduct a thermodynamic assessment. NUPACK3,4 was used for conducting the
thermodynamic assessments to determine which bases from candidate sequences
are likely to bind genomic sequences. Simultaneously, coverage is considered by
counting the number of bases from candidate sequences likely to pair with genomic
sequences.
Unfortunately, this is a resource-intensive search, so a shorter toy problem
has been attempted here. Using all of the 112 candidate sequences returned for
detecting serotype 1 against serotype 4, an assessment of coverage and binding
probability was performed against the first 500 bases of 30 genome sequences from
serotype 1. Any base from the candidate sequences that had a 90% or higher
likelihood of being paired with the genome at equilibrium is plotted in a histogram.
The existence of pairs occurring indicates both thermodynamic likelihood (existence
of pairs on plot) and coverage (count of pairs on plot). The output suggests whether
hybridization of the target to the appropriate region of the genome is likely to occur.
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Figure 3. Run time of target search algorithm for differing threshold values. Search
was performed for query word length = k and subject word length = k. As threshold
is lowered time of algorithm run increases.

5.4 Results
The target selection algorithm has been run multiple times over the course of
its development in optimizing it to improve speed and other aspects. In assessing
the speed of algorithm run versus settable parameters, target search was initially
attempted with Shiga toxin-producing E. coli (STEC) genome segments. Initially it
was discovered that if the threshold was set too stringently (higher values), the
algorithm didn’t return any candidates. Lowering the threshold improved chances of
returning targets, as exemplified by longer run times with each step-down of
threshold. No targets were returned until the threshold was lowered sufficiently.
Length of query word size and subject word size were also varied (in tandem as the
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both can be varied independently in this implementation), and results show that
decreasing word size in both query and subject increase the likelihood of returned
candidates. It seems likely that run times correspond to likelihood that the algorithm
will return results. This is because comparisons take time and the more
comparisons that are conducted, the longer the associated run-time. Words that
survive comparisons go on to other comparisons. The more comparisons that any
query word survives, the longer the associated run-time. The algorithm enjoys
speed gains whenever query words are discarded, as they no longer contribute to
further comparisons. Accepting that run times are a surrogate for higher likelihood
of returned results, in 19 runs of the algorithm, it is evident that decreasing the
length of query and subject words results in an increasing likelihood of returning
targets (Figure 3). Additionally, it is seen that decreasing threshold value results in
more likely return of candidates, noted as an increase in runtime (Figure 3). The
lowest LD threshold attempted for each word size corresponds to the first attempt
that returned results. The number of candidate targets returned by the algorithm at
this point are shown in Figure 4. In general, lower threshold and smaller word size
result in more returned sequences.
Returning to the objective of finding candidate sequences for probes in
dengue virus, the algorithm has been run for dengue target search. Shown in Table
1, are the results of the 12 database comparisons run at a threshold LD of 6 with
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word size of 20 for both query and subject. There is a wide variation of returned
results from only one potential target to 121 returned candidates.

Figure 4. Number of results returned by target search algorithm for differing
threshold values. Search was performed for query word length = k and subject word
length = k.
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Table 1: Table of Target Results. Results from multiple searches, each using one
database as the query and a second database as the background. All searches
were conducted using a threshold distance of 6, query word size of 20 bases, and a
background word size of 20 bases. Number of results are featured. Searches using
higher thresholds returned no results, so 6 is the maximum useable threshold.

As the algorithm searches for candidates based entirely on a distance metric
with no incorporation of physical parameters, it is necessary to attempt to assess the
real-world utility of recovered sequences. This was done using a thermodynamicbased structural assessment of a population of returned targets and their interaction
with the portion of the dengue genome that corresponds to these targets. Figure 5
shows an example NUPACK3,4 output featuring secondary structure and likelihood of
probe binding for a portion of a genome sequence and a candidate probe, both from
serotype 1. The sample genome sequence is the first 500 bases (starting from the
5’ end) of the dengue genome D1/Taiwan/709TN0706a. The candidate probe was
chosen from D1/Hu/Philippines/NIID13/2016. The native secondary structure in this
portion of the genome may be appreciated as indicated by stem loops and
intramolecular base pairs. The probe (as seen in the inset in Figure 5) only pairs
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with six bases of the genome sequence. The binding probabilities for these pairs
are in the 40-50% range, indicating that this probe does not pair well with this
genome.

Figure 5. Using NUPACK software3,4, secondary structure of a portion of a sample
dengue genome are shown along with binding likelihood of a candidate probe from
search. 500 bases starting from the 5’ end of dengue virus 1 strain
D1/Taiwan/709TN0706a is shown and the secondary structure of this region may be
appreciated. Candidate probe chosen from D1/Hu/Philippines/NIID13/2016 is
shown binding in the inset. Only six bases from the probe are shown bound, and the
likelihood of pairings are low with probabilities in the 40%-50% range. Binding
probabilities are given by the base color.

To assess binding likelihood of probes and simultaneously assess coverage,
only probe bases with binding probabilities over 90% are selected in the subsequent
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investigation. Using NUPACK3,4 to determine binding probabilities of bases, all of
the 112 candidate probes for serotype 1 against a serotype 4 background (Table 1)
were assessed against 30 serotype 1 genome sequences (Figure 6). The NCBI
accession numbers are shown to the left of corresponding histograms. The ticks on
the y-axis correspond to 5 bases. It can be appreciated that no genome had more
than 11 probes binding with more than 90% probability in any one location. Probe
identity was not assessed in this investigation, so it is difficult to say how many
probes were involved. Many probes are likely to be eliminated based on the low
number of pairings occurring in any location. Since the cut-off of probability for
binding s 90%, the indication is that any probes that are chosen at any of these
positions is likely to be a good probe.
Coverage also appears to be good for most of the genomes assessed as
indicated by multiple regions where pairing is occurring. The most promising sites
occur where there are continuous regions of binding for close to 20 bases,
potentially indicating a single probe. Again, it would be particularly useful to know
the probe identities, and this will be included in the next assessment.

5.5 Discussion
In this work, we have developed an algorithm to search for potential target
sequences for nucleic acid strand-displacement probes to detect. While much of
this work is preliminary, it suggests that a simple algorithm might be used for
sequence-based target search. This work also implies basic details about the kinds
of results that might be achievable using this kind of search. Fundamentals of
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sequence targeting considered here include length of probe, length of target region,
and threshold of distance discoverable.
Target length falls under the rubric of word length in the algorithm. Results
showed that the shorter the word length in query and subject considered in the
algorithm, the more results attainable at any particular threshold. There is an
associated periodicity to this trend as threshold is lowered (Figure 4).
There is interplay between threshold values and word size. Reconsidering
word size, it can be said that the smaller the word size, the smaller the threshold
value needs to be before positive results are returned. Raising the threshold at any
particular word size results in fewer returned sequences, or a decreased likelihood
of returned sequences. So higher threshold values are too specific and do not
return query words. Only when the threshold is lowered to a certain value does the
algorithm return words.
These results suggest fundamental limits in the ability to detect differences in
sequences using direct hybridization detection. This can pose a problem with realworld specificity. For example, at a word size (in query and subject) of 10 bases, no
results are returned until the threshold is lowered to LD 1. This corresponds to a
single base difference between the words (although this is 10% of the probe length).
As previously mentioned, the direct hybridization method used in our biodetection
scheme is unable to detect SNPs. So, using targets based on a 1 bp difference will
not be assayable using this technology.
While it is instructive to observe what the limitations are on a distance-based
target search, it is important to consider the final thermodynamic state of the
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components of the assay in order to achieve a final design. It is difficult to predict
where self-binding and other unwanted structures occur based on inspection alone.
For example, the software NUPACK3,4 models structures of oligonucleotides at
thermodynamic equilibrium based on experimentally determined nearest neighbor
free energies of base pair combinations6,8. Processing target sequences, probe
sequences and assay elements in NUPACK will show if any unwanted structures
occur in the final configuration.
NUPACK has been used here to rule out candidate probes that bind with less
than 90% likelihood to a sample subsequences from 30 genomes. This use of
NUPACK simultaneously assesses binding probability (by exclusion) and coverage
of target genome sequences by the candidate probes.
As this is only a sample of potential interactions, it is only suggestive of
coverage for these probes and targets. It will be instructive to expand the search to
the entire probe population as well as the entire genome, or possibly the entirety of
the genome database. This would be a much more intensive search that would
require more computing resources but would give a more informative appraisal of
probe binding probabilities.
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Figure 6. Histogram of serotype 1 coverage of probe candidates in a search of
serotype 1 against a serotype 4 background. 112 probe candidates and each of 30
serotype 1 genome sequences were analyzed with NUPACK3,4. NCBI accession
number for each of the 30 genome sequences is shown on the y-axis. Base position
from the 5’ end of the genome sequence is shown on the x-axis. Ticks on the y-axis
correspond to every 5 bases from probes that bind with a greater than 90%
probability to the genome at that position.

While the algorithm thus far has been based on sequence comparisons,
physical constraints are an important factor that has not yet been worked into
consideration. It is reasonable to add thermodynamic constraints to the algorithm as
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a next step. Scoring based on metrics output by NUPACK3,4 will be one method for
reflecting physical limits in the model. Parameter space of the structural output will
be explored using this updated basis. More promising would be to integrate or use
tools that have been built around target selection. ThermonucleotideBLAST13
searches for potential PCR targets using scores based on thermodynamics. This
suite is particularly promising as a candidate with a physical foundation that might be
used as a basis for target search. Exploring the assay’s parameter space using
these tools will reveal additional real-world limitations on the ability to detect analyte
based on direct hybridization. This work may show that there are fundamental
limitations to what can be done with this type of biodetection scheme.
While coverage has been assessed on a small scale here, the algorithm itself
should back-compare against the query database to assess coverage of query
database by the targets. This can be done using Blast comparisons or another
comparison metric (including LD). This is necessary to determine how much of the
query database is included with these query words. If, for example, all of the target
sequences come from a single genome, then it is effectively not possible to make a
positive detection of the serotype that was queried because not all species will be
detected.

5.6 Conclusion
The assay that has been developed for the serotype specific detection of
dengue virus has shown promise, but there are also some potential obstacles that
need to be overcome. A central aim for the assay is the ability to specifically identify
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serotypes present in samples. To accomplish this, appropriate target selection is
essential. For this work, an algorithm that uses a distance-based search routine to
discover potential strand displacement probes was developed. The algorithm
compares potential probe sequences to target regions on the genome of an
opposing serotype using the Levenshtein distance metric. A population of potential
target sequences has been produced for all pairwise comparisons of serotype that
may now be used for future iterations of the assay. Based on initial thermodynamic
assessments, this population appears likely to bind to targets. This algorithm
combined with further thermodynamic assessment will produce probe sequences
that can be used in the next iteration of dengue assay to assure serotype specific
detection and identification.
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Chapter 6.
Stochastic Kinetic Model of DNA Logic Assay for Dengue Virus.

6.1 Abstract
Assay development involves validation by various metrics. Detection limit is
one of the more important as this is the lower limit of concentration of analyte that
can be detected. This is essentially the lower limit of the potentially useful range of
the assay. It is important to be able to detect pathogens at clinically relevant or low
levels of concentration. This ensures that the analyte or pathogen is not missed. If
a model of the assay can be devised that characterizes the detection limit, this might
inform assay design. Detection limit is frequently based on the noise of the blank.
This intrinsic stochasticity in the definition of detection limit suggests that an
appropriate model would also include stochasticity. This work is the beginning of a
project to develop a stochastic kinetic model of the DNA dengue assay. The current
implementation uses a stochastic simulation algorithm (SSA, or the Gillespie
algorithm), but it could also be developed using stochastic differential equations
(SDEs). The results suggest that the noise in the assay can be recapitulated using
the SSA-based kinetic model.

6.2 Introduction
In assay design, there are important metrics used for validation. Among
these is determination of the limit of detection (LOD) of the assay (Not to be
confused with the limit of the blank and the limit of quantitation). An assay must be
able to determine the difference between background noise and the presence of
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analyte. The quantitative description of this level is the LOD. The LOD has been
formally defined as 3 times the standard deviation of the blank, divided by the
analytical sensitivity1 (or slope of the detection calibration, Equation 1).

Equation 1. IUPAC definition of the Limit of Detection (Long, 1983). The
concentration of the detection limit (cL) equals the number of standard deviations (k)
times the standard deviation of the blank (sB) divided by the analytical sensitivity, or
slope (m).

To facilitate rational design of the DNA-nanotechnology-based bioassay with
respect to LOD, it is of value to have a kinetic model that incorporates LOD. A
theoretical prediction of LOD for DNAzyme sensors can be made using the
assumption that the least DNAzyme concentration that generates an abovethreshold signal corresponds to the LOD. This has been performed for binary probe
split DNAzymes2. Methods of determining a model for LOD include an analysis of
potential experimental errors and their potential contribution to experimental
precision for enzyme-linked immunosorbent assay3,4. Using the Equation 1
definition of LOD, the core component of this metric is the noise in the blank. Noise
in the blank is inherently stochastic, originating from the random fluctuations of
molecules in the sample, the detector, or of photons hitting the detector.
The goal of this work is to build a stochastic kinetic model and use it to
characterize or suggest a theoretical limit of detection in the DNA-nanotechnology-

131

based bioassay. Ability to recapitulate sources of detection limit in a model may
guide future design decisions.
The basis of the stochastic model used here is the well-known kinetic Monte
Carlo variant, the Stochastic Simulation Algorithm or Gillespie Algorithm5. There are
two components to the basic algorithm which form the source of the stochastic
behavior. These are two random numbers which are drawn in each iteration and
correspond to the choice of reaction to occur and the length of the next time step.
It is important to mention, that in contrast to deterministic modelling which is
based on gross measures like concentration of reactant, stochastic modelling is
based on the fine measure of number of molecules. This means that only small
portions of volume can be reasonably modelled, but the source of the stochasticity is
captured by the variability in which reaction fires, and when.
An additional complication here is that as the number of molecules of analyte
are decreased, seeking the lower limit of detection, the amount of the assay
molecules becomes much greater than the amount of analyte molecules. This
creates a difficulty in creating a model because there are species occupying two
very different regimes. Relatively large amounts of assay components are better
modelled by deterministic, continuous models, while the small amounts of analyte
are better modelled by stochastic, discrete simulation.
Solutions to this dichotomy may exist in the form of hybrid and multiscale
models6,7. These algorithms have been built to deal with systems that contain large
differences in concentration or rate such as the recapitulation of biological models.
These may incorporate assumptions such as the stochastic steady state
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assumption6,7, but if properly conceived will allow the modelling of a system
containing these differences and enable a stochastic model of LOD to be built.

6.3 Methods
6.3.1 Wet-lab experiments
Synthetic oligonucleotides were designed using NUPACK8,9 software for
determination of strand interaction at thermodynamic equilibrium. DNA and modified
DNA species were synthesized using the solid-phase synthesis technique by IDT
DNA (Coralville, Iowa), and shipped lyophilized. All oligos consisted of
deoxyribonucleotide elements, with the exception of substrate which additionally
contained a ribonucleotide at position 9 and had 6-carboxyfluorescein (FAM) and 6carboxytetramethylrhodamine (TAMRA) conjugated to the 5’ and 3’ ends
respectively. Stock oligos were resuspended in RNAse-free water (Sigma-Aldrich,
St Louis, MO). Enzyme-inhibitor complex was formed by mixing enzyme with
inhibitor at a 15% excess and annealing on a heat block at 95° C for three minutes,
followed by a two-hour cooldown. All components of the assay were prepared by
serial dilutions from stock in buffer with RNAse-free water containing 50 mM
HEPES, 1 M NaCl, and 1 mM ZnCl2.
Dengue assay experiments were performed in triplicate on a 96-well plate.
Each experiment consisted of the following samples: background, negative control
(leakage), and samples with a series of concentrations of target molecule. The
series of target concentrations were 1 pM, 5 pM, 25 pM, 125 pM, 625 pM, and 5 nM.
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Background sample contained only substrate at 50 nM. All other samples
contained fuel and enzyme-inhibitor complex at 5 nM, and substrate at 50 nM. The
target samples mentioned above contained target at that concentration, while
negative control had no target sample.
Components were mixed to the final concentrations mentioned above with
enzyme-inhibitor complex being added last, just before acquiring data. Data
acquisition occurred on an M2e plate reader (Molecular Devices, San Jose, CA),
exciting at 492 nm and reading 518 nm emittance. This was performed over a 17hour time-course, reading every 5 minutes.

6.3.2 Limit of Detection
To prepare data for LOD calculations, the negative control was subtracted
from all target samples. These were then normalized to the average of fluorescence
values for the 5 nM reaction upon reaching completion. For each of the triplicate
experiments, LOD was calculated at every time point according to Equation 1 with k
set at 3. sB was calculated as the standard deviation of the negative control
samples. At each time point, a linear regression of the all the concentrations was
performed, the slope of which was used as m in Equation 1. These were plotted for
each replicate and a 2nd order exponential (as an estimate of central tendency over
this time period) was fit to these points. The minimum value of this trend was used
as an estimate of the optimal LOD for this replicate.
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Scheme 1. Enzyme – substrate reaction scheme with two products.

6.3.2 Simulations
Simulation was performed for two kinetic reaction models. One model
consists of the probable steps for the enzyme-substrate cleavage reaction. The
other model contains the reactions that occur for the full dengue reaction.

Table 1. Rate constant values for enzyme and substrate reaction. Rate constants
correspond to those from Scheme 1.

The minimal reaction steps arrived at for the enzyme substrate reaction are
shown in Scheme 1. The minimal reaction steps arrived at for the full reaction are
shown in Scheme 2. Rate constants used in the simulation for the enzyme-
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substrate simulation and the full dengue assay reaction are shown in Tables 1 and
2, respectively.
The simulation algorithm was originally written using MATLAB (Mathworks,
Natick, MA), but was ported to Python. The stochastic simulation was the Gillespie
algorithm5 and was partially based on an implementation in MATLAB10.
For the stochastic model of the enzymatic reaction, an expanded version of
the reaction model in Chapter 4 was used in which substrate cleavage resulted in
two products which could be released in either order (Scheme 1). The activated
intermediate was still left out of the model as experimental resolution is too low.

Scheme 2. Minimal kinetic model of full reaction scheme with dual products and
leakage pathway.
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The enzyme-substrate reaction was modelled using the rate constant values
in Table 1 which correspond to the reactions in Scheme 1. These values are based
from values derived from continuous, deterministic modelling.
For the stochastic algorithm, rate constants from previous fits were converted
from continuous values to discrete probabilities. Concentration of reactants was
converted to number of molecules. An implementation of the Gillespie direct method
in MATLAB was used10. Length of time steps was determined by random number
generation and a second random number was used to determine which reaction
would fire on the basis of propensities (determined by probability and number of
molecules). At regular intervals, updated values of molecule quantity were sampled
for later plotting. A time course of levels of each reactant over a single simulation is
shown in Figure 2 where substrate levels gradually decrease as both products
increase. For the full reaction simulation, values from the model in Scheme 2 were
used. Change of levels of these reactants can be seen in Figure 5 for a simulation
using a target concentration of 5 nM.
The full dengue assay reaction scheme shown in Scheme 2 was modelled
using the Gillespie algorithm. Values chosen for rate constants are given in Table 2.
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Table 2. Rate constant values for full reaction mechanism shown in Scheme 2.

6.4 Results
Triplicate experiments were run with a range of decreasing concentrations of
target strand (the synthetic version of the analyte sequence). For each experiment,
at each time point, a linear regression of the target concentrations versus signal
yielded slope for the LOD calculation. A double exponential was fit to a plot of the
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LOD for each replicate at all time points and the minimum of this curve was
determined to yield the optimal time point and minimum LOD (Figure 1). Based on
these fits, it was determined that the minimum LOD falls in the range of 60 pM – 80
pM and the optimal time point for an end-point assay occurs between 42 and 57
minutes.

Figure 1. Determination of minimal LOD and optimal time point for end point assay
for three replicates. Data was acquired for multiple time points during a kinetic run
of the assay at multiple target concentrations. For each time point LOD was
calculated using Equation 1. A double exponential was fit to a plot of LODs over
time and the minimum of this plot determined optimal time point and minimum LOD.

The enzyme-substrate reaction was modelled using the rate constant values
in Table 1 which correspond to the reactions in Scheme 1. These values are
derived from continuous, deterministic modelling. An example of a simulation run for
the enzyme substrate reaction for all reactants and products is shown in Figure 2. It
is clear that levels of most reactants do not change dramatically with the exception
of substrate, product P, and product Q. Substrate begins at 602 molecules and
drops to close to zero molecules, while the products increase from zero molecules to
a range of 550 to 580 molecules. The reaction is essentially complete by 200
minutes when product P “peaks” at 572 molecules (product Q peaked at 555
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molecules at 190 minutes). Levels of P and Q continue to oscillate stochastically
around a mean of 571 and 555 molecules respectively for the remainder of the
simulation time. Enzyme begins at 60 molecules and is consumed within 5 minutes,
remaining at 0-5 molecules for most of the reaction. Enzyme-substrate complex
rises to about 15 molecules in the first 10 minutes, but then drops off to a steady
state level of near zero around 55 minutes and remains there for most of the
remainder of the reaction. EPQ remains at a mean of 20 molecules for the duration
of the observed simulation. EQ and EP oscillate around a mean of 27 and 10
molecules respectively.

Figure 2. Plot of change in number of molecules of all reactants and products over
the course of a single simulation of the enzyme-substrate reaction as shown in
Scheme 1. Rate constants from Table 1 used in simulation.
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Converting simulation output from discrete values to continuous and
normalizing by maximum concentration allows for comparison of simulations with
wet-lab data. Figure 3 shows a normalized plot of three replicates of wet-lab results
plotted alongside three simulations. This shows that there is significant variation of
wet-lab data as compared with the simulation, but that the simulation lies within the
variance of the wet-lab experiments.

Figure 3. Plot of three replicates of experimental data with three simulations of the
enzyme-substrate reaction model.

Figure 4 shows the variance in the normalized mean of 301 simulations as
compared with that of the triplicate wet-lab experiments. This reveals that the
instrumental variance overpowers the stochastic variation in the system.
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Figure 4. Normalized plot of three replicates of experimental data with 301
simulations of the enzyme-substrate reaction model. Error bars are 1 standard
deviation.

The results for a single simulation of the full reaction are shown in Figure 5.
All reactants and products present in the model have been simulated. The major
change, as with the enzyme-substrate reaction is with substrate and products P and
Q. Substrate begins at 602 molecules and drops to zero by 395 minutes where it
remains for the remainder of the time. Products P and Q begin at nothing and then
increase respectively to 600 molecules at 370 minutes and 595 molecules at 425
minutes. After this point, P oscillates around a mean of 602 molecules while Q does
so around 595. Other reactants initially present in the system, begin at 60 molecules
and the drop to a steady state level by an hour and 15 minutes. By 75 minutes, fuel
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drops to a steady state level of 2 molecules, target drops to 7 molecules, and
enzyme-inhibitor complex has dropped to zero. Enzyme goes from zero to 50
molecules in 140 minutes and then oscillates around that mean for the remainder of
the simulation. In 70 minutes, 50 molecules of target-fuel-inhibitor (TFI) complex
have developed, apparently the maximum amount of reaction by-product that will
form. The intermediate complex TEI, where target has bound the enzyme-inhibitor
complex, rises to a peak of 18 molecules at 5 minutes, then tapers down to 3 at 70
minutes. FEIQ, the complex of fuel and product Q bound to the enzyme-inhibitor,
appears quickly and oscillates around a mean of 7 molecules for the duration of the
simulation. The remainder of the intermediates remain around zero for most of the
simulation.
Plotting 3 replicates of normalized wet-lab data alongside the results of 3
simulations reveals that the simulation elements are reacting slower than the actual
data (Figure 6). This is confirmed by comparing the mean of the wet-lab triplicate
with that of 301 simulations (Figure 7). While the mean output is slower in the model
as compared with the data, the variance of both are comparable for the first 250
minutes or so. Following that, the standard deviation of the simulations becomes
negligible.
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Figure 5. Plot of change in number of molecules of all reactants and products over
the course of a single simulation of the full dengue assay reaction as shown in
Scheme 2. Assumed concentrations of starting elements are 50 nM of substrate (S)
and 5 nM of enzyme-inhibitor complex (EI), fuel (F), and target (T). Rate constants
from Table 2 used in simulation.
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Figure 6. Plot of three replicates of experimental data with three simulations of the
full dengue assay reaction model.
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Figure 7. Normalized plot of three replicates of experimental data with 301
simulations of the full dengue assay reaction model. Error bars are 1 standard
deviation.

Simulation in the absence of target is revealing. It is clear that the leakage
reaction results in lower rate of substrate cleavage and production of product (Figure
8). Over the 1020-minute course of the simulation, substrate is not reduced below
260 molecules. Product P and Q have increased to 337 and 284 molecules
respectively in the same time period. The plot shows that the amounts gradually
creep to these levels in this time frame and the stochasticity is much more evident
on the plot. Not much enzyme is released, with no more then 3 free enzyme
molecules being present at any one time. Likewise, complexes involving enzyme
remain in the low single digit numbers for the course of the reaction. This includes
ES (enzyme-substrate), FEI (fuel-enzyme-inhibitor), and FEIPQ (fuel-enzyme146

inhibitor-cleaved products). On the other hand, FEIQ (fuel-enzyme-inhibitor with
lingering product Q) accumulates, growing to 50 molecules by 170 minutes and then
hovering around a mean of 52 molecules for the rest of the reaction. Fuel and
enzyme-inhibitor complex drop in tandem to 3 molecules at 370 minutes. The
remainder of the reactants are essentially non-existent for the entirety of the
reaction.

Figure 8. Plot of change in number of molecules of all reactants and products over
the course of a single simulation of the full dengue assay reaction as shown in
Scheme 2, but in the absence of target. Assumed concentrations of starting
elements are 50 nM of substrate (S) and 5 nM of enzyme-inhibitor complex (EI) and
fuel (F). Rate constants from Table 2 used in simulation.

The stochasticity of the reaction is more clearly appreciated in Figure 9 which
shows three simulations plotted alongside triplicate experimental data. The
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stochastic runs vary from a slow increase to a level almost two times higher than the
wet-lab to a more rapid increase and kinetics that appear to better mimic in situ data.
In general, the runs appear to be slower than experiment at early time points,
universally resulting in higher output values. One simulation does taper to a rate of
rise that parallels experiment.

Figure 9. Plot of three replicates of experimental data with three simulations of the
full dengue assay reaction model in the absence of target.

The variance in the simulations is better appreciated in a plot of the mean of
301 sim replicates (Figure 10). Variance in the leakage pathway appears to be
higher than that of the reaction with 5 nM of target as the standard deviation for the
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assay in absence of target is 0.1072 as opposed to 0.0327 in the presence of target.
This is likely due to the lower concentrations of intermediates involved with leakage.

Figure 10. Normalized plot of three replicates of experimental data with 301
simulations of the full dengue assay reaction model in the absence of target. Error
bars are 1 standard deviation.

6.5 Discussion
A stochastic kinetic model has been developed for the dengue assay. We
have explored a model of the enzyme-substrate reaction with two products. We
have also investigated the minimal kinetic model resolved for the full reaction
mechanism. This includes the so-called leakage pathway that occurs in the absence
of target.
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Experimentally-determined limit of detection is observed to be in the range of
60 pM to 80 pM. This is consistent with limit of detection observations made by
various groups about DNAzymes which range from 5 pM to 630 pM (with two
outlying values of 50 fM for DNAzymes conjugated to gold beads and 5 nM for a
reaction that incorporates an entropy-driven amplifier)11. This appears to be an
experimentally-determined hard limit on lower detection limit. It would be valuable to
confirm this in a model.
It is instructive to examine the outputs that the stochastic model produces for
both consideration of reaction progress trends and the effect of stochasticity.
Outputs of the simulation show progress of intermediates (Figures 2, 5, and 8),
revealing that most reactants remain at negligibly low quantities for the majority of
the reaction. Not surprisingly, the substrate and products represent the reactants
that achieve the highest quantities because of the excess of substrate that is used in
the reaction. There are a few other key reactants that rise to a higher level over the
reaction course. Notably EP and EQ (enzyme complexed with one of the products)
remain at slightly elevated levels, indicating that there is some residual product that
sequesters enzyme in the two-product model.
In the full reaction, the TFI construct (Target-fuel-inhibitor waste complex) has
apparently reached equilibrium by about 70 minutes, while the levels of product
continue to rise. Free enzyme also continues to rise given that as substrate is used
up, less enzyme is bound. In the full reaction with target, the same trends are
observed with both TFI and free enzyme. The TFI reaction has essentially
equilibrated by 70 minutes, with free enzyme continuing to rise to about 140
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minutes. Despite this, the overall reaction runs slower than the naked enzymesubstrate reaction, because the strand-displacement must occur first for there to be
enzyme available for catalyzing substrate. It is curious that the enzyme remains at a
stable level of 50 molecules over the course of the full reaction when it is depleted in
the enzyme-substrate reaction. Perhaps the additional pathways that enzyme can
follow keep it cut off from substrate, sequestering it away before it can interact with
substrate.
The leakage simulation predictably shows a slower exhaustion of substrate
and production of products. The reactant that is notable for attaining a higher
concentration than most is FEIQ (fuel-enzyme-inhibitor-product Q complex),
revealing that product Q fails to be quickly released here, sequestering the active
form of enzyme in the leakage pathway.
It is notable in Figures 3, 4, 6, 7, 9, and 10 that the simulations and the
experimental data deviate from each other during the key portion of early kinetics.
The data and simulations for the enzyme-substrate reaction (Figures 3 and 4) are
most closely aligned with the simulations falling within 1 SD of the data mean for
most of the simulation (Figure 4). Simulations of the full reaction in the absence of
target also overlap for much of the reaction, with the data occupying an area within 1
standard deviation of the simulation mean (Figure 10). This is largely due to the
large variation in the simulations, as the shape of the curve of the simulation mean
does not recapitulate that of the data mean (Figure 10). It is clear in the plots of the
full reaction in the presence of target that the experimental kinetics do not overlap
with the simulation kinetics (Figures 6 and 7). It is clear that the rate constants
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chosen for these simulations are not appropriate for this model. The stochastic
model has not yet been corroborated with the deterministic model. The stochastic
model still uses two products being produced in each cleavage reaction as opposed
to one for the deterministic. The use of two products in the model allows for more
degrees of freedom which in principle could enable a better fit, but this fit has still
been elusive. Future iterations of the stochastic model should be pared down to
single product cleavages.
It is already clear from this model that at zero concentration of target there is
significant effect from stochastic fluctuations (Figure 10). The difference in reaction
progress between simulations is marked (Figure 9) and suggests that modellable
stochasticity will yield insights about the reaction at low levels of target.
Remaining is to explore how the simulation changes with levels of target that
are much lower than the other reactants as would occur at very low concentrations
approaching the limit of detection. This regime occurs with the target in low
concentrations that are better modelled with SSA, while the remainder of reactants
are at high enough levels that a continuous model would be appropriate. This
necessitates using a hybrid model that is designed to deal with dramatically different
regimes of molecule quantity.
Gillespie (among others) has experimented with developing hybrid models
that will accommodate models that contain fast and slow reactions but may also be
used with high and low concentrations of reactants6. Developed with the
intercellular regime in mind, the slow-scale stochastic algorithm deals with the issue
of stochastic stiffness by splitting the reactants into slow-scale and fast-scale
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reactants6,7. Slow-scale will follow a stochastic progression, while fast-scale
reactants will be approximated by a change in the mean value of quantity instead of
the actual value6,7.
The next step will be to reconcile the stochastic and deterministic models to
get a better fit of data and simulation. Then we will build a hybrid model, based on
the current scheme with updated parameters. Using this model, we will be able to
observe how stochasticity in low level targets affects reaction progress.

6.6 Conclusion
This work has produced a kinetic model of a DNA strand-displacement and
DNAzyme cascade that employs a stochastic algorithm. This model will be suitable
for exploring the effect of molecular fluctuation on the enzyme at low concentrations
of assay target. Improvements will be made to the model in the form of reconciled
rate constants and hybrid format. These enhancements will make the model more
consistent with wet-lab experiments and better able to deal with regimes with
extreme differences in concentration. Together with the continuous model, this work
provides tools that will facilitate future characterization of DNA-based detection
assays.
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Chapter 7.
Future Directions and Conclusion.

7.1 Future Directions
Current trends in pathogen spread demand new detection methods. The
work discussed in the present volume is an attempt at a step forward in developing
new physical techniques for detection and new approaches for computational design
of assays. The effort is far from finished, as many potential research directions
suggest themselves. The subsequent course to be pursued for computational
design has been discussed in previous chapters. Considered here are two
promising directions for a rethinking of the physical assay. The first solution posed
involves use of a portable acoustic technology for enhancement of signal against a
matrix background used in the test case of Shiga toxin-producing Escherichia coli
(STEC). The second idea addressed is the potential integration of DNA molecular
logic technology into a next generation sequencing (NGS) assay. Although the
possibilities presented are not exhaustive, they are both encouraging of paths for
future research.

7.1.1 Negative Acoustic Contrast Assay for Signal Enrichment
In the preliminary work performed so far, the pathogen target is Shiga toxinproducing E. coli (STEC), a pathogenic microorganism found in human food sources
such as beef. STEC has proven to be a major cause of foodborne illness, affecting
the beef industry, restaurants, and individuals. The presence of this microorganism
in the food supply is a public health threat and outbreaks sicken people and put
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companies at risk. A portable, easy-to-use, rapid assay would facilitate testing of
stocks, potentially preventing contaminated food from making it to restaurants and
supermarkets. To this end, we seek to use separation of sample and assay by
attachment to negative acoustic contrast particles (NACPs) and enrichment by
acoustophoretic separation of NACPs from positive acoustic contrast elements using
acoustic device technology1.
One of the challenges in assay development is matrix effects. The sample
source for a clinical assay will often be human tissue or blood, as biopsied tissue or
blood draws are common sources. The blood sample may be further processed into
serum or plasma. For a STEC detection assay, the sample may come from animal
tissue. Any of these sample sources constitute a biological matrix, from which the
analyte must be separated or in which the assay must function.
Performing a ligand-based or optical assay in vitro will result in matrix
effects2,3. A sample originating from a biological source contains a background
matrix of any number of components not related to the analyte of interest: protein,
nucleic acid, lipid, whole cells and tissue fragments. Any additional background will
potentially interfere with the functional components of the assay or the signal of the
report due to matrix effects. This can be dealt with by prior sample preparation,
including dilution, protein precipitation, liquid or solid phase extraction 2–4. In a
laboratory, sample analyte is separated from matrix by a number of technical steps
such as centrifugation, filtering, and multistep processes that require trained
technicians and equipment to perform. These are technologies that may not easily
be made portable. For the dengue assay characterized in this volume, RNA
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extraction was performed on the live virus sample prior to application of the assay.
This ensured a minimum of background optical interference. For a point-of-care
(POC) or lab-on-a-chip assay, the separation process must be portable and
automated. Acoustophoresis is a promising technology for portable separation, as
the footprint of the necessary piezoelectric is small and the technology enables
separation of components based on acoustic contrast.
Acoustophoretic separation of components takes advantage of inherent
properties of materials. Application of a standing ultrasonic wave to a sample will
result in migration of microparticles based on their acoustic properties5. Acoustic
properties of the microparticles are based on particle volume, particle density with
respect to the medium, and particle compressibility with respect to the medium.
Density and compressibility determine the contrast factor (Φ) which indicates
whether the microparticle is negative or positive contrast (determined by sign of Φ)6.
Positive acoustic contrast particles (PACPs) will move to the node of the standing
wave while negative acoustic contrast particles (NACPs) will move to the antinode of
the standing wave6. This property may be taken advantage of in order to separate
components of a sample. Most biological components (cells) have positive acoustic
contrast, so using a microparticle with negative contrast as an assay component will
allow separation of the assay microparticle from the bulk matrix containing primarily
positive components.
The unified sensor architecture has been adapted to work on a bead-based
assay. Linker strands were incorporated for attachment of the assay elements onto
microparticles. The detection module has had STEC target sequences incorporated.
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For microparticles, we are using polydisperse polydimethylsiloxane (PDMS) beads
that we fabricate in house1. PDMS has the properties of sufficiently low
compressibility and density, resulting in negative contrast.
For conjugation of linker strands to beads we have used carbodiimide
chemistry with 1-Ethyl-3-(3-Dimethylaminopropyl)carbodiimide (EDAC). Using the
EDAC molecule effectively as a catalyst, a carboxyl group is conjugated to an amine
group. Due to PDMS having ready interaction with silane, a carboxysilane will be
used to coat the bead, thus carboxylating the bead. DNA with amine functional
groups will be synthesized. These linker strands will be conjugated to carboxyl
group on the surface. The complementary regions of the assay will pair with the
linker strands and the final result is a bead-based assay.
Currently, we have tested conjugation chemistry of test DNA strands with
fluorophore to PDMS microparticles. Treating beads with a carboxysilane, and then
subsequent addition of DNA and EDAC should result in conjugation of the test
strands to the surface of the beads. This is tested by running the beads through a
flow cytometer and interrogating for the fluorophore on the test strand. Results show
that conjugation has successfully occurred.
The assay beads will be mixed with biological sample, allowing analyte
detection to occur. Application of the acoustic wave will separate the beads from the
rest of the sample which will be removed using flow. Beads can then be collected
for optical interrogation. This effectively enriches the assay signal above what would
occur while still ensconced in the matrix.
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Subsequent steps will be to test assay designs on PDMS microparticles to
ensure proper functioning of the assay. Following that, the assay will be conjugated
to NACPs and acoustophoretic enrichment will be attempted. Once the assay works
under these conditions it will be tested with a biological sample containing STEC or
a synthetic STEC target sequence to see if enrichment can be performed in the
context of a biological matrix. The results of this work will be a functioning
enrichment scheme to be used in conjunction with the hybridization assay

7.1.2 DNA Logic Expression Profile Assay
Based on experimental evidence, the lower limit of detection of the modular
gate cascade system appears to be in the tens of picomolar. An analyte of interest
can frequently have femtomolar or attomolar concentrations in clinical blood
samples. This means that using the current architecture, particularly high sample
concentrations might be detectable, but for clinical relevance there are further
modifications to the assay that need to be made. In this work, a number of solutions
are being attempted including enrichment and kinetic design. Further amplification
is also a possibility: either a preamplification of target nucleic acid prior to the assay,
or an additional amplification of the assay reporter production. Another, more
intriguing possibility is to detect the host mRNA for indication of disease state.
Gene expression profiling is becoming increasingly important for
understanding cell state, and has been used to predict prognosis and outcomes for
breast cancer,7,8 prognosis of dengue virus infection,9,10 and has even been used to
characterize Autism11. The transcriptome of a cell at any particular instant is a
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reflection of cell type, behavior, and environment. Although perhaps not as accurate
as the proteome for understanding what functionality is being expressed, mRNA
identity is easier to access. There are currently a number of transcriptomic
technologies, including quantitative-PCR, high-throughput sequencing, and gene
expression microarrays. These technologies have the disadvantage of high cost,
run-time, and the need for extensive computational analysis of the results to
determine the meaning of the profile12.
DNA molecular computation could provide the analysis of the profile results in
vitro, decreasing run-time and cost. Through direct hybridization DNA molecular
components can detect any particular nucleic acid sequence, and thus can be used
to detect expressed mRNA, resultant cDNA, or the products of PCR. Combined with
a DNA-based logic circuit, the results of detection of different levels of different
mRNA could be parsed (by a classifier) and then transferred to a resultant report,
fluorescent or otherwise. One implementation of a DNA-logic based classifier of
gene expression profile currently exists. Lopez et. al.13 trained a classifier in silico
on existing expression data using a support vector machine, then ported this
classifier to a DNA-based design, and successfully classified two clinical scenarios.
Their method shows that a DNA-logic based classifier can work in this context.
One way to combine NGS and universal sensor architecture would be a
design in which DNA molecular logic is conjugated on a microarray surface to funnel
expression information from host cells into a DNA-based classifier to detect
presence of a dengue infection. The chosen cDNA sequences would be used as the
toehold and complementary sequence of the detection module. Upon displacement
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of the inhibiting strand, instead of release of an enzyme, an ssDNA indicating
weighting of that element will be released to feed into the classifier.
The classifier will need to be developed prior to implementation in a DNA
cascade. There exist already a number of published expression profiles for patients
with dengue9,10. These profiles are indicative of prognosis of disease and stage of
disease. An assay that could detect mRNA, determine the profile from those
detections, and give a diagnosis or prognosis would be highly valuable, particularly if
made for point-of-care diagnosis. Use of a neural network may be valuable to train a
classifier based on this data. Initially, imposing a limitation on the number of strands
necessary for a classification would facilitate design of an implementation with fewer
strands. Once an appropriate classifier is found, the DNA classifier could then be
implemented. It could follow a scheme similar to Lopez et. al.13, using multiple
targets for weighting, but there may be a simpler method that doesn’t require the
difficulty of finding multiple contiguous targets.
Following design of cascade, smaller groups of elements will be tested to
ensure proper function, then tested in larger groups until the full cascade is verified.
Following this, the linker elements will be printed to a microarray and the assay will
be tested with synthetic DNA (corresponding to the appropriate mRNAs) following
the same technique that would be used for cDNA printing14,15. For final testing, the
mRNA could be expressed in bacterial or cell-free culture to provide full-size targets
to test the assay on. The collected eluate from the array could then be collected for
optical interrogation.
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An alternative method would be to use a bead-based assay not unlike the
acoustophoretic assay suggested above and use flow cytometry to read the assay
results. In this case weighting would be done by fluorophore with different
fluorophores used for positive and negative weighting. The final component of the
classifier might still be processed afterword in silico, but would be a simple sum of
positive count and negative count, with the molecules doing all of the weighting.
The end goal of this project would be either a POC microarray assay that
would give information about disease state, prognosis, and stage, or a simple flow
cytometric readout that would give the similar diagnostic information. Although not
POC, the flow cytometric assay would be quick and easy to perform, with a minimum
of technical expertise beyond that of operating the flow cytometer. One could
envision a lab-on-chip flow-based assay that could be portabilized. Although the
final result of this project would detect pathogens by profile, this work could
contribute a general detection scheme for diagnosis that could be used for any
disease that gives a unique expression profile. For molecular profiling, this solution
would improve speed, cost, and ease of use.

7.2 Conclusions
The results of the effort discussed in this volume are technologies that
facilitate sequence-based molecular diagnosis. The applications extend from
detection of viral and bacterial pathogens to the gene profiling of tumor cells. Using
DNA molecular computation technology as the basis of sequence-based diagnostics
has resulted in new capabilities and methods of design. We are able to find a range
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of sequence-based targets specific against a chosen background. We are able to
model the kinetics of the universal sensor architecture in order to make fine-tuned
design decisions. We are able to model the limit of detection of the system to
determine inherent limitations of the system. We have learned limitations of the
system with respect to complex environments such as samples containing live virus.
This work advances the fields of diagnostic assays and DNA molecular logic
technology.
There is much future work to be done to follow up on the results here. The
models will be used to further fine tune the assay and molecular components to
achieve more favorable kinetic profiles leading to more specific and sensitive
detection. Incorporation of acoustophoretic enrichment components onto assays will
facilitate implementation of lab-on-chip or point-of-care assays. Work will be done to
port the assay to other analytes and disease systems that would benefit from this
assay technology. Targets and clusters of targets will be chosen by algorithm. The
microarray-based assay will be useful for detecting any types of cell expression
profiles, beyond those relating to pathogens. A particularly promising application
would be to classify cells based on oncogene expression profiles. Finding profiles
that are indicative of cancer risk or prognosis would be of great value for clinical
cancer medicine.
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